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NON-MEDICAL USE OF PRESCRIPTION STIMULANTS FOR WEIGHT LOSS: 
PREDICTORS, CONSEQUENCES, AND IMPLICATIONS FOR INTERVENTION IN A 
NATIONAL YOUNG ADULT SAMPLE 
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Philosophy at Virginia Commonwealth University. 
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Department of Psychology 
 
The non-medical use of prescription drugs is an important public health concern. 
Non-medical use of prescription stimulants (NMUPS), specifically medications used to treat 
Attention Deficit Hyperactivity Disorder (ADHD), is particularly concerning. One timely 
concern regarding NMUPS, especially among young adults, is their role in appetite 
suppression/weight loss. Indeed, some individuals are motivated to misuse such drugs for the 
purpose of losing weight. Engaging in NMUPS for weight loss has been examined only 
minimally in the research literature. However, extant data demonstrate that this behavior is 
associated with other unhealthy behaviors and poor psychosocial health. Limitations of prior 
	  	    
research include the exclusive use of college student samples and little attention to relevant 
health behavior theory. The current study investigated NMUPS for weight loss in a national, 
young adult sample (n = 1526), ages 18-25 years, utilizing Amazon’s Mechanical Turk. 
Motivations and attitudes about NMUPS were evaluated, within the framework of the Theory 
of Planned Behavior (TPB). A structural equation model (SEM) was analyzed, which 
included attitudes; social norms; and perceived behavioral control (PBC) to lose weight 
without stimulants, as predictors of engaging in past year NMUPS for weight loss. 
Approximately 12.0% of participants reported lifetime NMUPS for weight loss, and of these, 
48.4% reported past year use. Findings demonstrate that use is related to disordered eating 
and unhealthy weight loss behaviors, including vomiting; high rates of other substance use; 
and psychological concerns, including body dissatisfaction and depressive symptomatology. 
These results suggest that NMUPS for weight loss is associated with a variety of negative 
consequences and users are not well-informed regarding medication knowledge. The SEM 
provided adequate overall fit to the data; two of the four social norms and both PBC factors 
were significantly associated with NMUPS for weight loss. This study extends the literature 
on the utility of the TPB in examining NMUPS, and provides the first research on utilizing 
the TPB to examine NMUPS for weight loss. Methods aimed at increasing PBC regarding 
stimulant use and weight loss, and emphasizing healthful and sustaining weight loss 
strategies, improving mental health, and educating about polysubstance use are potential 
intervention targets. 
 
 
 
	  1 
Non-medical use of prescription stimulants for weight loss: Predictors, consequences, and 
implications for intervention in a national young adult sample 
Non-medical Use of Prescription Drugs 
In recent years, there has been a dramatic increase in the non-medical use of 
prescription drugs (NMUPD), including the use of psychotropic or analgesic medications 
(e.g., pain relievers, tranquilizers, sedatives, stimulants) without a physician’s prescription, as 
well as the intentional misuse of one’s own medication among young adults. Consistent with 
the definition used in the Substance Abuse and Mental Health Services Administration’s 
(SAMHSA) National Survey on Drug Use and Health, “NMUPD” will be used in this paper 
as the umbrella term to describe use without a prescription, as well as intentional misuse of 
one’s own prescription (e.g., use too much, use to get high, or use to increase other drug or 
alcohol effects; SAMHSA, 2012). Thus, this commonly used definition includes both those 
who use prescription drugs without a doctor’s prescription and those who intentionally 
misuse their own prescription drugs. However, when necessary, distinctions between non-
medical use versus intentional misuse will be made clear. 
Motives for NMUPD include: to get high, for experimentation, to enhance energy, 
relieve pain, and to lose weight (Jeffers & Benotsch, 2014; Jeffers, Benotsch, & Koester, 
2013; McCabe & Cranford, 2012). In national studies, as many as 29.2% of young adults 
(18-25) report NMUPD in their lifetime (Institute for Behavior and Health, n.d), with almost 
6% reporting NMUPD in the past month (SAMHSA, 2012). In 2012, a young adult in the 
United States (U.S.) was more likely to use a prescription drug non-medically than to use any 
illicit substance except marijuana (SAMHSA). NMUPD now accounts for more emergency 
room (ER) visits than use of all illicit substances combined (SAMHSA, 2012). Data from 
	  2 
other national samples have demonstrated that NMUPD is a risk factor for future drug 
dependence (Schepis & Krishnan-Sarin, 2008), binge drinking (McCauley et al., 2011), and 
substance use disorders (Schepis & Hakes, 2011). NMUPD has been associated with poor 
mental health, including depressive symptoms, suicidality, and anxiety (Dussault & Weyandt, 
2013; Zullig & Divin, 2012). NMUPD has also been related to sexual risk behavior, 
including more sexual partners and unprotected sex (Benotsch, Koester, Luckman, Martin, & 
Cejka, 2011). 
Non-medical Use of Prescription Stimulants 
One particularly concerning trend is the rise in the non-medical use of prescription 
stimulants (NMUPS; Arria & DuPont, 2010; Rabiner et al., 2009). Lifetime prevalence rates 
are estimated as high as 34% among college students (DeSantis, Webb, & Noar, 2008). 
Motivations for NMUPS include: to help with concentration, to increase alertness, to get high, 
and for the sake of experimenting (Teter, McCabe, LaGrange, Cranford, & Boyd, 2006). 
NMUPS is associated with adverse health effects including increases in heart rate, blood 
pressure, body temperature, and malnutrition due to a decrease in appetite (National Institute 
on Drug Abuse [NIDA], 2009). Chronic stimulant use can lead to paranoia and hostility and 
high doses can lead to cardiovascular consequences (NIDA, 2009). Mixing prescription 
stimulants with drugs or alcohol can exacerbate these side effects (Higher Education Center, 
2012). NMUPS has been associated with other substance use including use of alcohol, 
tobacco, marijuana, cocaine, and ecstasy (Lanier & Farley, 2011). Indeed, NMUPS is 
associated with past year alcohol or drug use disorders in both males and females (Wu, 
Pilowsky, Schlenger, & Galvin, 2007). Further, between 2005 and 2010, the number of ER 
visits related to NMUPS increased dramatically from 5,212 to 15,585 (SAMHSA, 2013). 
	  3 
One timely concern regarding NMUPS, especially among young adults, is their role in 
appetite suppression.  
NMUPS for weight loss. Prescription stimulant medications used to treat Attention 
Deficit Hyperactivity Disorder (ADHD), for example, Adderall and Ritalin, have shown 
promise for improving the main symptoms of ADHD and enhancing academic performance 
among those with ADHD (Zachor, Roberts, Hodgens, Isaacs, & Merrick, 2006). However, a 
common side effect of these medications is appetite suppression (Zachor et al., 2006) and 
subsequent weight loss (Kent, Blader, Koplewicz, Abikoff, & Foley, 1995). Because of this 
widely known side effect of ADHD medications, and given the increasing number of young 
adults who report a desire to lose weight (Neumark-Sztainer, Wall, Larson, Eisenberg, & 
Loth, 2011), some individuals are motivated to misuse such drugs for the purpose of weight 
loss (Jeffers & Benotsch, 2014; Jeffers et al., 2013). Further, there is a widespread 
misperception that prescription drugs are safe even when taken without a prescription (NIDA, 
2013). This misperception, and the ease of obtaining these substances, contribute to their 
frequent non-medical use. Indeed, many individuals who share medications are unaware of 
their dangers and procure them for free from a friend or relative (NIDA, 2013). Thus, 
stimulant medication might seem like a cheap, easy way to lose weight. Engaging in the non-
medical use of prescription ADHD medication for the purpose of weight loss has been 
discussed in the popular press, but has been examined only minimally in the research 
literature, has rarely been a focal point of research, and has been examined exclusively in 
college students (e.g., Jeffers & Benotsch, 2014; Jeffers et al., 2013; Rabiner et al., 2009; 
Teter et al., 2006). 
	  4 
In one study, the non-medical use of specific prescription stimulants was examined 
along with the motives for such use in a random sample of college students (n = 4580; Teter 
et al., 2006). About 9.7% (n = 37) of the lifetime users reported using stimulants not 
prescribed to them for the purpose of weight loss. However, this motivation was the sixth 
highest reason given after motives such as improving concentration, as a study aid, and 
increasing alertness. The use of prescription stimulants for weight loss was minimally 
examined in this study. Rabiner and colleagues (2009) examined the misuse of ADHD 
medication among individuals who reported having a current prescription for these 
medications (n = 115), of which 27 reported misuse. Motivations for misusing prescription 
stimulants were discussed, including for the purpose of losing weight. However, this was not 
a focal point of the research as this behavior was minimally endorsed within the sample. 
Judson and Langdon (2009) found that 3.6% of individuals reported non-medically using 
ADHD medication to lose weight in a sample of 333 students (both prescription and non-
prescription holders). DeSantis and colleagues (2008) examined non-medical use of 
prescription ADHD medications among college students and found that among the 585 
participants that reported use without a prescription, 5% reported using for the purpose of 
suppressing appetite. This motive was also mentioned in qualitative interviews the 
researchers conducted. For some participants, appetite suppression was a beneficial side 
effect to use, and for some it was the primary motive. For example, one participant who 
reported studying as the main motive of NMUPS said, “It is kind of cool that you also don’t 
want to eat either” (DeSantis et al., 2008). Another participant reported, “The first time I 
used it was because one of my sorority sisters told me how great it was. She said you don’t 
want to eat, and it is safe and everything” (DeSantis et al., 2008). 
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NMUPS for weight loss as a focal point. To the PI’s knowledge, only two studies 
have focused strictly on NMUPS for the purpose of weight loss (Jeffers & Benotsch, 2014; 
Jeffers et al., 2013). In the first of these studies, 11.7% of young adults (n = 705) surveyed 
reported having used a prescription stimulant for weight loss (Jeffers et al., 2013). 
Individuals who reported using prescription stimulants for weight loss were more likely to 
report dieting, had greater appearance-related motivations for weight loss, greater emotion 
and stress-related eating, a more compromised appraisal of their ability to cope, lower self-
esteem, and were more likely to report engaging in other unhealthy weight loss and eating 
disordered behaviors such as vomiting, using laxatives, utilizing a fad diet, and skipping 
meals. Indeed, these individuals were eight times more likely to engage in these behaviors.  
However, a limitation of the Jeffers et al. (2013) study included not clearly 
differentiating between those who misused their own ADHD medication from those who 
received medication from another source. Thus, the researchers were unable to differentiate 
between individuals who were misusing their own medication for the purpose of weight loss 
(i.e., for a purpose other than was intended) versus those who were receiving medication 
from others for the purpose of weight loss (i.e., non-medical use). 
A follow-up investigation examined NMUPS for weight loss, recreational drug use, 
disordered eating, and body image (Jeffers & Benotsch, 2014). This study examined young 
adults’ (n = 707) NMUPS, in general and for weight loss, other recreational and illicit drug 
use, perceived effectiveness of NMUPS for weight loss, eating disordered behaviors and 
symptomatology, and body image. Current ADHD prescription holders were excluded from 
this study because these medications are sometimes prescribed off-label for weight loss 
(Bernstein, 2006; Johnson, 2006), and the researchers wanted to account for this possibility. 
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Moreover, they wanted to focus the investigation on users who did not actually have a 
prescription but were getting the medication from another source. Approximately 4.4% of the 
sample engaged in NMUPS for weight loss. Individuals who engaged in NMUPS for weight 
loss had problematic attitudes and feelings related to eating, including a high level of concern 
regarding dieting and weight. These individuals also engaged in problematic eating behaviors 
and had higher eating disorder symptomatology. Indeed, vomiting to control one’s weight 
and shape, as well as laxative, diet pill, or diuretic use, were robustly associated with 
NMUPS for weight loss. There was also an association with binge eating, but this relation 
became nonsignificant when examined from a multivariate perspective. Individuals who 
engaged in NMUPS for weight loss had lower body appreciation and higher body image 
concerns, specifically related to the media. Individuals who used stimulants for weight loss 
were also more likely to use other recreational drugs, including marijuana, cocaine, 
methamphetamine, and hallucinogens.  
Theory of Planned Behavior 
 One limitation of these prior studies is that they were largely atheoretical. Applying a 
health behavior theory to a problematic behavior can provide a useful framework for better 
understanding the constructs related to that behavior, which can aid in developing 
interventions. The Theory of Planned Behavior (TPB; Ajzen, 1991; Ajzen, 2002) postulates 
that intention to engage in a particular behavior is a result of personal attitudes toward the 
behavior, social norms, and perceived behavioral control.  
Within this model, attitudes refer to the degree to which a person has a positive or 
negative evaluation or appraisal regarding a certain behavior, and encompass beliefs about 
possible consequences or other attributes of the behavior. Social, or subjective norms, are 
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perceived social pressures to engage or not to engage in a particular behavior, and concern 
expectations of important others. Finally, perceived behavioral control refers to individuals’ 
perceptions of their ability to perform a specific behavior. Perceived behavioral control is 
assumed to reflect both past experiences and future circumstances with respect to the 
behavior. Both self-efficacy (i.e., perceived ability to perform a behavior) and controllability 
(i.e., beliefs about whether performing the behavior is up to the individual) items should be 
incorporated when measuring perceived behavioral control, although control can be treated 
as a unitary factor depending on the purpose of the research (Ajzen, 2002). Taken together, 
these three constructs form a behavioral intention. Intentions are believed to encompass the 
motivational factors that influence a behavior, and, along with perceived behavioral control, 
account for a large proportion of variance in actual behavior (Ajzen, 1991).   
The TPB and examinations of health behaviors. The TPB has been shown to 
predict various health-related behaviors, including exercise (Nguyen, Potvin, & Otis, 1997), 
diet (Conner, Kirk, Cade, & Barrett, 2003), as well as addictive behaviors including binge 
drinking (Collins & Carey, 2007), smoking (Van De Ven, Engels, Otten, & Van Den Eijnden, 
2007), and illicit drug use (Morrison et al., 2010). For example, Collins and Carey (2007) 
examined the TPB in relation to binge drinking in college students and found that drinking 
refusal self-efficacy and attitudes predicted intention. Further, intention predicted Time 2 
binge drinking. Van De Ven et al. (2007) found that smoking-related cognitions predicted the 
onset of smoking via intention among adolescents with and without asthma. The TPB has 
also been used to predict marijuana use among unmarried pregnant adolescents (Morrison et 
al., 2010). 
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TPB and NMUPD. The TPB has also been used to predict NMUPD, and NMUPS, in 
particular. Judson and Langdon (2009) used the TPB to examine NMUPS in college students 
(n = 333) with and without ADHD prescriptions. Participants were recruited from two New 
England colleges and the sample was predominantly White (89%). Prescription holders and 
non-prescription holders were compared on a variety of domains, including motives for use, 
knowledge of medication side effects, and TPB constructs. NMUPS for non-prescription 
holders was defined as using stimulant medication without a prescription. NMUPS for 
prescription holders included using stimulant medications in excess or for purposes other 
than intended (i.e., treating ADHD). Results were consistent with the TPB, particularly for 
non-prescription holders, such that they had fewer concerns regarding adverse health effects 
and ethics of use, higher perceived positive social norms, and lower perceived behavioral 
control (i.e., felt more dependent on stimulant medications). Judson and Langdon (2009) did 
not directly measure intention to use, but the relation between these beliefs and attitudes were 
directly related to NMUPS. As previously mentioned, 3.6% of participants reported weight 
loss as a motive for NMUPS. However, it is unclear whether this motive was endorsed by 
prescription holders, non-prescription holders, or both. Moreover, the investigators did not 
focus on this motivation in their study. 
In a dissertation study, Gallucci (2011) created a survey instrument using TPB 
constructs (including modified items from Judson and Langdon’s [2009] work) to examine 
NMUPS and diversion behavior (e.g., selling medications, sharing among friends) among 
undergraduates aged 18-24 (n = 1026). Gallucci did not directly measure intention to use, but 
attitudes and perceived behavioral control were related to lifetime NMUPS, with the latter 
being the strongest predictor of lifetime NMUPS; social norms, however, were not related. 
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Gallucci mentioned that the social norm variables (e.g., beliefs held by relevant others) were 
associated with higher numbers of participants who had incomplete data. He posited that 
participants’ unwillingness to answer these questions might be attributable to the survey 
administration (e.g., close proximity to friends in the classroom during survey completion). 
Only perceived behavioral control was related to recent non-medical use (i.e., past 30 days; 
Gallucci, Martin, Beaujean, & Usdan, 2015). Findings indicate that some elements of the 
TPB are related to lifetime NMUPS, and that the TPB has limited utility in predicting recent 
NMUPS, at least for the past 30 days, in undergraduates ages 18-24.   
In a master’s thesis, Srigley (2013) examined behavioral intentions to use prescription 
stimulants, depressants, and opioids non-medically within the next year in a sample of 131 
college students. Both attitude toward use and perceived behavioral control emerged as 
strong predictors of intention to engage in NMUPD.  
Finally, Ponnet and colleagues (Ponnet, Wouters, Walrave, Heirman, & Van Hal, 
2015) examined Flemish college students’ (n = 3,589) intention to engage in NMUPS for the 
purpose of enhancing academic performance. They used an extended model of the TPB and 
found that subjective norms, followed by attitudes and perceived behavioral control predicted 
intention to use, among other variables (e.g., substance abuse, procrastinating tendencies). 
Overall, few studies have examined the TPB as it applies to NMUPS. The four 
aforementioned studies have resulted in inconsistent results and warrant further research to 
determine the ability of the TPB to predict NMUPS (e.g., Gallucci, 2011). Moreover, two of 
the four studies involved small samples (e.g., 131 and 333) with the exclusive use of 
undergraduate students.   
NMUPS in College Students and Non-College Students 
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 The majority of studies examining NMUPS among young adults have focused on 
college students, as prevalence rates of NMUPS are typically higher in this population 
compared with their non-college peers (Herman-Stahl, Krebs, Kroutil, & Heller, 2007). This 
is not surprising given the commonly reported motives for NMUPS related to improving 
academic performance (Herman-Stahl et al., 2007). College students may also have greater 
exposure to individuals using prescription medications (both for medical and non-medical 
purposes; Herman-Stahl et al., 2007). However, NMUPS prevalence rates vary and range 
from 3-36% (McCabe, Teter, & Boyd, 2006) in college student samples depending on 
geographic location and school admission standards (Gallucci, 2011).  
 Relatively few studies have examined NMUPS in non-college populations (e.g., 
Herman-Stahl et al., 2007; Wu et al., 2007). Although there is evidence to support higher 
prevalence rates in college populations, non-college young adults are also at risk for 
engaging in this behavior. Kelly and colleagues (2013) found that in a sample of socially 
active young adults who participate in urban nightlife (n = 1207), 44.1% reported lifetime 
NMUPD, with NMUPS as the most prevalent in the past 6 months (16.7%). Although the 
authors did not report on college attendance rates, it is highly probable that this community 
sample consisted of both students and non-students. As the authors concluded, a contribution 
of this study included moving beyond college student samples to lend insight into non-
medical use across a spectrum of young adults (Kelly et al., 2013). Additionally, results from 
the 2013 Monitoring the Future (MTF) survey demonstrated that annual prevalence rates of 
Adderall misuse were somewhat higher for college students (9.0%), but 6.7% of their non-
college peers also endorsed the behavior (Johnston, O'Malley, Bachman, & Schulenberg, 
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2013). Further, prevalence rates of Ritalin misuse are much lower than rates of Adderall but 
rates were not different for college students (1.8%) and non-college students (2.6%).  
 Clearly, NMUPS is not limited to undergraduate students. Further, although most 
research suggests higher rates of this behavior in college student populations, prevalence 
rates are also concerning in their non-college counterparts (e.g., 6.7%; Johnston et al., 2013). 
Moreover, academic-related motives for NMUPS (e.g., improve academic performance) are 
undoubtedly more salient among college students, but it is likely that non-academic related 
motives (e.g., appetite suppression) are just as prevalent among non-college populations. 
Research is warranted to examine NMUPS in a national sample of young adults to gain a 
more comprehensive picture of the behavior, specifically as it relates to weight loss. 
Gaps in the Research 
Although promising, limitations of the existing research concerning NMUPS for 
weight loss include the exclusive use of college student samples and relatively little attention 
to relevant health behavior theory. Because NMUPS for weight loss is associated with poor 
psychosocial health and health-jeopardizing behaviors, further research is warranted to 
examine factors such as motivations and attitudes that are amenable to change. The paucity 
of literature also warrants further investigation of individuals’ knowledge of risks of the 
medication, negative consequences associated with NMUPS, age of onset, and how they 
decided to try this behavior. The current study has attempted to address these gaps in the 
literature. 
The Current Study 
This innovative study investigated NMUPS for weight loss in a national, young adult 
sample, and assessed its relation with other problematic cognitions and health behaviors, 
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including disordered eating. In addition, motivations and attitudes about NMUPS were 
evaluated, as these constructs might be most amenable to change in a future intervention. 
Moreover, this investigation focused on users who did not actually have a prescription but 
received medication from another source (i.e., non-medical use), as these individuals are 
typically at greater risk for adverse effects (e.g., cardiac effects; Benson, Flory, Humphreys, 
& Lee, 2015). Accordingly, this project’s specific aims and relevant corresponding 
hypotheses were:  
Aim 1: To examine the prevalence of NMUPS for weight loss in a broader, national 
sample of young adults. Young adults, ages 18-25, were recruited because they are the group 
most likely to engage in NMUPS (SAMHSA, 2012) and are also at high risk for disordered 
eating behaviors (Neumark-Sztainer et al., 2011).  
Aim 2: To investigate correlates of NMUPS for weight loss, including negative 
consequences associated with this misuse (e.g., medical, psychological), age of onset, factors 
influencing participants’ decision to use prescription stimulants for weight loss, knowledge 
about these medications (e.g., adverse effects, contraindications), medication source, and 
perceived effectiveness of NMUPS for weight loss. 
 Aim 3: To evaluate the utility of the TPB model to predict membership in one of 
three groups: individuals who have engaged in NMUPS for weight loss in the past year; 
individuals who have tried to lose weight via other methods in the past year; and those who 
have not tried to lose weight in the past year. 
Hypothesis for Aim 3: Individuals who have engaged in NMUPS for weight loss will 
have more favorable attitudes toward the behavior (e.g., view the behavior as ethical), view 
the behavior as common, and have lower perceived behavioral control to lose weight without 
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the help of stimulants, as well as higher perceived behavioral control to obtain stimulant 
medication compared to the other two groups.  
 Aim 4: To compare the three groups on additional relevant behaviors and constructs: 
disordered eating behaviors, body image, other substance use, and depressive 
symptomatology.  
Hypothesis for Aim 4: The three groups will differ on various constructs, such that 
individuals who engage in NMUPS for weight loss will have poorer body image, higher rates 
of disordered eating, higher rates of other substance use, and greater depressive 
symptomatology compared to the other two groups.  
Method 
Research Design 
Amazon’s Mechanical Turk. The current study utilized a survey aimed at assessing 
NMUPS for weight loss in a national sample of young adults recruited from Amazon’s 
Mechanical Turk (MTurk), an increasingly popular online method for recruiting large 
samples at relatively low cost. Online data collection, particularly regarding surveys, is 
popular and increasingly trusted in the scientific community (e.g., Casler, Bickel, & Hackett, 
2013). This data collection poses no greater concern to data integrity and quality compared 
with more traditional data collection methods (e.g., Casler et al., 2013). In particular, recent 
research has demonstrated that MTurk samples are diverse, data can be collected efficiently 
and inexpensively, data quality are high, and there is incentive to take the time to complete 
tasks satisfactorily. Further, recent literature, such as a paper by Mason and Suri (2012) has 
included steps and “how to” information for researchers that might be interested in utilizing 
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MTurk (Casler et al., 2013). MTurk has been successfully used to recruit participants for 
survey, longitudinal, and experimental research (Shapiro, Chandler, & Mueller, 2013). 
Brief overview. MTurk started out in 2005 as a platform for humans to complete tasks 
that are extremely difficult or impossible for computers (e.g., audio transcription), and has 
since also become a place for scientists to conduct behavioral research (Mason & Suri, 2012). 
In MTurk language, this online labor market allows for employers (called requesters; e.g., 
researchers) to post a task, or HIT (Human Intelligence Task; e.g., online survey) for 
prospective employees (called workers; participants) to complete in exchange for a wage 
(called reward; incentive; Paolacci, Chandler, & Ipeirotis, 2010). MTurk is a crowdsourcing 
site with one of the largest participant pools, thus data can be obtained quickly. There is 
typically a stable pool of potential participants from which to recruit inexpensively (Ipeirotis, 
2010; Mason & Suri, 2012). Prior research demonstrates rapid data collection rates (Mason 
& Suri, 2012; Shapiro et al., 2013). For example, Shapiro and colleagues (2013) recruited 
participants to complete a study on well-being and mental health, which included items 
assessing depression, anxiety, satisfaction with life, and personality. The survey took 
approximately 20 minutes to complete and participants were given $0.75 as an incentive. The 
authors collected data from 530 participants in two days. Additionally, Ipeirotis (2010) had 
participants complete a survey assessing demographics and information regarding MTurk 
participation that took approximately 3 minutes to complete. Participants were given $0.10 
for participation. The survey was conducted over a three week period, and they collected data 
from 1000 MTurk participants.  
Low cost. One main advantage of MTurk is the low cost of conducting studies (with 
built-in payment mechanism; Mason & Suri, 2012; Paolacci et al., 2010). Incentives can be 
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as low as $0.01 and rarely exceed $1.00 (Paolacci et al., 2010). In terms of an hourly wage, 
the average MTurk participant is willing to work for $1.40 an hour (Paolacci et al., 2010). A 
concern often posed is that lower pay equals lower quality work, however, as will be 
discussed subsequently, this is typically not the case and there seems to be little to no 
influence of incentive on the quality of work (Mason & Suri, 2012). For example, Mason and 
Watts (2009) found that the number of tasks participants completed increased with greater 
incentive (from $0.01 to $0.10) but that the data quality were the same. Moreover, 69.6% of 
U.S. MTurk workers reported that “MTurk is a fruitful way to spend free time and get some 
cash (e.g., instead of watching TV)” (Ipeirotis, 2010; Mason & Suri, 2012; Paolacci et al., 
2010). Many people find MTurk money as a nice way to pay for “extras” (Mason & Suri, 
2012). Non-monetary motivations include: for entertainment purposes and “killing time.” 
Thus, most people are not trying to make a living using MTurk (less than 8% reported 
earning greater than $50/week), and many are willing to participate for lower pay than they 
might otherwise (Mason & Suri, 2012).  
Diverse participant pool. Another major benefit of using MTurk is the recruitment of 
diverse participants. Research has shown that MTurk samples are more diverse than college 
student samples and that recruiting very large samples is feasible (Mason & Suri, 2012; 
Shapiro et al., 2013). Demographic surveys show that MTurk participants from the United 
States are similar to the national population, and that they are much more representative than 
participants from traditional university subject pools, though they are typically younger than 
the general population (Paolacci et al., 2010). Participants come from widespread geographic 
locations, are more ethnically diverse, and economically varied compared to typical 
academic samples (Casler et al., 2013). Moreover, MTurk samples are also more diverse in 
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terms of ethnicity and economic status compared with samples recruited via social media 
(e.g., Facebook, Twitter; Casler et al., 2013). MTurk samples are comparable in demographic 
characteristics to community-based samples and the relations between key demographic 
characteristics (e.g., age, gender) and health behaviors are similar for MTurk and community 
samples (Shapiro et al., 2013). In addition, the estimated prevalence of mental health 
problems (depression, social anxiety, substance use) found in MTurk samples closely 
matches those of the U.S. population (Shapiro et al., 2013). 
Good data quality. Prior research suggests the data quality from MTurk are high 
(Mason & Suri, 2012; Paolacci et al., 2010; Shapiro et al., 2013). For example, Buhrmester 
and colleagues (Buhrmester, Kwang, & Gosling, 2011) compared personality data collected 
from MTurk with data collected using the same measures in traditional settings and found 
concordance in findings. There was no evidence of random or otherwise problematic 
responding in the data collected on MTurk and the psychometric properties (e.g., test-retest 
correlations, coefficients alpha) of surveys using the two formats were nearly identical. 
Shapiro et al. (2013) also found satisfactory internal and test-retest reliability for mental 
health measures on MTurk. Moreover, they demonstrated criterion validity by replicating 
established associations between psychopathology and demographic predictors (e.g., 
unemployment).  
Casler and colleagues (2013) took a behavioral, traditionally in-person task and 
converted it to an online format. Participants were shown four pairs of simple tools: one 
familiar object demonstrated performing its typical function and one highly similar (in 
appearance) novel object. In one condition, the “teaching” trials, the novel tool was named 
and shown performing its action. In the “non-teaching” trials, the tool was named but only 
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described in terms of non-functional features (e.g., color). In the in-person condition, 
participants were allowed to hold the tools, and in the online format, participants viewed 
videos with close-up shots of the objects three times. Participants were then introduced to a 
different, unrelated task and were asked to choose which tool they needed to complete the 
task. The authors then compared responses of participants recruited from MTurk, participants 
recruited from social media postings, and a traditional sample of college students who 
completed the task at a lab in-person. The expected behavioral outcome (i.e., choosing the 
novel tool in non-teaching trials and no preference for novel tool in teaching trials) was 
evident in all three recruitment conditions; thus, there was no difference in the response 
pattern among the groups. The authors concluded that online recruitment and testing, and 
MTurk in particular, can be a valid, and sometimes, even superior method than in-person 
data collection. Additionally, Gardner and colleagues (Gardner, Brown, & Boice, 2012) used 
MTurk to investigate body size estimation and dissatisfaction, and compared the results of 
this study to those of three prior studies. All four of these studies used the same assessment 
scale (i.e., Body Image Assessment Scale; Gardner, Jappe, & Gardner, 2009), but employed 
different methodologies (group data collected in a classroom, individually in a lab, and 
online via a university student web portal). Despite the different methodologies and sample 
characteristics, comparable values were obtained in all four studies. The authors agreed with 
Buhrmester et al. (2011) that quality data can be obtained inexpensively on MTurk, and that 
MTurk is a viable method for collecting data related to body image and other areas of 
psychology. 
Moreover, MTurk has an approval rating system based on prior performance on other 
MTurk “tasks” (e.g., surveys). Poor performance can lead to “rejection” of participants’ work, 
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thus reducing participants’ approval ratings, which can subsequently impact their 
participation in additional work including research studies. Further, researchers can require 
participants to have an approval rating above a certain threshold. This rating system serves as 
an incentive for participants to take tasks seriously (Casler et al., 2013). Gardner et al. (2012) 
also noted that some participants are interested and motivated by the tasks.  
Participant anonymity. An additional benefit is the anonymous nature of MTurk, 
where participant identities are masked from researchers thus increasing response rates 
(Shapiro et al., 2013). Prior work indicates that stigmatized health behaviors are more likely 
to be fully reported as anonymity increases and that computer assessments can be an 
important tool for data collection in this regard (Des Jarlais et al., 1999; Gosling, Vazire, 
Srivstava, & John, 2004). Studies assessing sensitive information such as substance use and 
eating disordered behaviors may well obtain more accurate data using web-based 
technologies than traditional methods. 
Creating a survey on MTurk. There are two ways to create HITs, or surveys, on 
MTurk: internal or external HITs (Mason & Suri, 2012). An internal HIT consists of using 
templates offered by Amazon. The development and all of the data collection are completed 
on Amazon’s servers. These HITs can be created quickly and with little HTML programming 
knowledge. However, a disadvantage is that they are limited to only single-page surveys. In 
an external HIT, the survey and data are stored on the researcher’s server. Advantages 
include increased control over the content and presentation of the survey (allowing multiple 
pages in a survey), and that the data are secure because they are not stored on Amazon’s 
servers as in an internal HIT. (Although Amazon says they will not touch the data, this is still 
a privacy concern, especially for behavioral researchers examining sensitive issues.) 
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Procedure 
 The current study utilized an online survey placed on Amazon’s Mechanical Turk 
website via an external HIT. Participants were able to view the title of the survey, description, 
number of timeslots available, and incentive amount. Additionally, the purpose of the study, 
risks/benefits of participating in the research, and contact information for the Principal 
Investigator (PI) and the university’s Institutional Review Board were provided in case the 
participant experienced distress as a result of the research. Participants provided informed 
consent by reading over the informed consent document and clicking on an “Agree” button 
(or “Cancel” if they did not want to participate), and then continued onto the survey. The PI 
frequently checked how many participants completed the survey, and subsequently approved 
participants’ work, which enabled them to be paid.  
 Security. Data were never stored on Amazon’s servers, but went directly from the 
participant to an external server managed by the PI. As an added security measure, the https 
protocol was used so that participants’ responses were encrypted during the data transfer 
process (Mason & Suri, 2012; Schmidt, 2007). 
 Quality assurance. Although rare, some workers simply care about the money they 
earn and not the quality of their work (typically referred to as spammers; Mason & Suri, 
2012). Additionally, there have been reports of programs (i.e., bots) that are designed to 
automatically complete HITs (Mason & Suri, 2012), which can negatively impact data 
quality. However, one safeguard from these occurrences is the inclusion of a question created 
to discourage spammers and bots; this type of question must require human knowledge and 
equal effort as additional questions in the survey, but have a verifiable answer (Mason & Suri, 
2012). This/these question(s) can be used to evaluate the work. Choosing questions with 
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topics that are not in line with the remainder of the study, should be clear to participants 
(workers) that they have been included to verify the legitimacy of the other survey responses. 
Five such questions were included in the current study. (It was made clear in the description 
of the study that participants who did not answer these questions correctly, would not be 
paid; Mason & Suri, 2012). To ensure both maximum data retention and fairness to 
participants, the PI paid participants who correctly answered four out of the five quality 
assurance questions (e.g., paid them and kept their data even if they skipped the “What do 
you think the purpose of this study was?" question).  
Participants 
 Power analysis. As the goal of Aim 4 was to compare/contrast those who engaged in 
NMUPS for weight loss, those trying to lose weight via other methods, and those not trying 
to lose weight, power to detect various effect sizes was explored using G*Power software. 
The power analysis was based on the multivariate analysis of covariance (MANCOVA; see 
analyses below), and the sample size required to detect a small effect size (Cohen, 1988) with 
a power level of .80 and alpha set at .05 to detect differences between groups for a 
MANCOVA was n = 64 for each group. In prior work, the prevalence of NMUPS for weight 
loss has ranged from 4.4% to 11.7% (Jeffers & Benotsch, 2014; Jeffers et al., 2013). Taking 
the conservative estimate into account (especially given that NMUPS is typically higher in 
college/university samples), the PI planned to recruit at least 1455 (64/.044) participants to 
obtain power ≥ .80. Moreover, the PI aimed to recruit at least 45 additional participants (for a 
total n = 1500) to account for response error, poor quality responses, and missing data. The 
power analysis thus facilitates detection of differences (i.e., small effect sizes) among the 
three groups on multiple constructs (e.g., body dissatisfaction, depressive symptomatology) 
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as a MANCOVA tests for multiple differences between groups. A sample size of 1500 was 
also sufficiently large to estimate the prevalence of NMUPS for weight loss (Aim 1). The 
power analysis for the MANCOVA was based on n = 192 (n = 64 x 3 groups). For the 
structural equation model (SEM), almost the entire sample was included (n = 1429), which is 
approximately seven times larger than the sample size on which the power analysis is based. 
The sample size for the SEM was based on the groups for the dependent variable; please see 
results section below. Therefore, the analyses were sufficiently powered (power > 0.80) to 
detect a significant effect (p < 0.05) for parameters with low to moderate effect sizes in all 
statistical models. 
Eligibility criteria and incentive. Participants (n = 1526; see Descriptive Results 
below), ages 18-25, were recruited from MTurk because they are the group most likely to 
engage in NMUPS (SAMHSA, 2012) and are also at high risk for disordered eating 
behaviors (Neumark-Sztainer et al., 2011). Participants were required to speak English and 
reside in the United States. Additionally, only participants who had an approval rate of 90% 
or greater (i.e., their work has been accepted by the requester or researcher at least 90% of 
the time) were allowed to participate, which is a common qualification on MTurk (Mason & 
Suri, 2012). They received $0.50 for their participation as low incentive rates are common in 
MTurk and rarely exceed $1.00 (Paolacci et al., 2010).  
Measures 
 The online survey allowed for branching of questions so that participants skipped 
questions that did not pertain to them. For example, a participant who never endorsed 
NMUPS was not subsequently asked about motivations for NMUPS. See Appendix A for the 
entire list of measures. 
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 Demographics. Participants were asked their age, race/ethnicity, gender, educational 
status, income, height, weight, whether they had ever been prescribed a prescription 
stimulant medication by a doctor to treat ADHD (e.g., Adderall, Ritalin), whether they were 
currently being prescribed a prescription stimulant medication by a doctor to treat ADHD 
(e.g., Adderall, Ritalin), whether they had a current prescription for any medication for the 
purpose of weight loss, whether they had ever tried to lose weight, whether they were 
currently trying to lose weight, how often they had tried to lose weight during the last year, 
place of residence (state), and whether they lived in a rural versus urban area. Body mass 
index (BMI) was calculated based on self-reported height and weight. 
 Quality assurance questions. To discourage spammers and bots, as well as to ensure 
good quality data, five verifiable questions were included: “Who is the president of the 
United States?,” “What would you want your last meal to be?,” “Please check the number 
four below: 1, 2, 3, 4, 5, 6,” “While watching the television, how often have you ever had a 
fatal heart attack?” (Response choices were: Never, Rarely, Sometimes, On a regular basis.), 
and “What do you think the purpose of this study was? (Please make your best guess.).” 
(Mason & Suri, 2012). 
 NMUPS frequency. NMUPS was assessed with the following question: “On how 
many occasions (if any) in (a) your lifetime or (b) the past 12 months have you used a 
prescription stimulant normally used to treat ADHD (e.g., Adderall, Ritalin, Concerta, 
Vyvanse), not prescribed to you?” The response scale ranged from 1 (No occasion) to 7 (40 
or more occasions). This question was modeled off of other commonly used questions to 
assess NMUPS (Johnston, O’Malley, Bachman, & Schulenberg, 2005; McCabe & Teter, 
2007; McCabe et al., 2011).    
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 NMUPS motivations. Participants who had ever engaged in NMUPS answered 
questions concerning motivations for non-medical use including “weight loss/appetite 
suppression,” “to get high,” “increased energy,” and “to increase concentration.” Motivations 
were assessed for lifetime and past year use. Similar items have been used in prior work 
(Jeffers & Benotsch, 2014). 
 Age of onset. Participants who had ever engaged in NMUPS reported at what age 
they began using stimulants non-medically. One question also specifically asked about age of 
onset for those who used non-medically for weight loss.  
 How they decided to try this as a weight loss strategy. One question addressed how 
an individual who engaged in NMUPS for weight loss decided to try this as a weight loss 
strategy: a) You knew someone else who was doing it, b) You heard about the idea from the 
media (e.g., TV, radio, Internet), c) Someone else gave you their ADHD medication 
specifically for that purpose, d) Other _______. 
 Medication source. Those who had engaged in NMUPS reported on the source of the 
medication: a) Friends, b) Family, c) Internet, d) Stranger, e) Other. This item has been used 
in prior work (Jeffers & Benotsch, 2014). 
 Perceived effectiveness of NMUPS for weight loss. Participants reported on the 
perceived effectiveness of NMUPS for weight loss from 1 (Not at all effective) to 4 (Very 
effective) as done in prior work (Jeffers & Benotsch, 2014).  
 Negative consequences associated with NMUPS. Participants who had engaged in 
NMUPS reported on negative consequences experienced as a result. Items were adapted from 
a Drug Use Consequences Scale developed by Palmer et al. (Palmer, McMahon, Moreggi, 
Rounsaville, & Ball, 2012) and the Shortened Inventory of Problems—Alcohol and Drugs by 
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Blanchard and colleagues (Blanchard, Morgenstern, Morgan, Lobouvie, & Bux, 2003), 
which was modified from its parent scale, the Inventory of Drug Use Consequences by 
Miller et al. (Miller, Tonigan, & Longabaugh, 1995). Examples include: “lost a close 
relationship” and “continued to use despite psychological or physical consequence.” The 
response scale ranged from 0 (Never) to 7 (40+ times in past year). 
 Medication knowledge. This section assessed participants’ knowledge of stimulant 
medication including side effects and adverse consequences, contraindications, as well as 
sources of exposure regarding this information, modeled after Judson and Langdon (2009). 
Items were also developed based off of the Physicians’ Desk Reference ("Adderall XR," 
2014; "Ritalin LA," 2014; and "Vyvanse," 2014).   
 Attitudes. Attitudes were assessed with questions regarding beliefs about adverse 
health effects and ethical considerations, modeled after a sample TPB questionnaire (Ajzen, 
n.d.-a) and Judson and Langdon (2009). Sample items include: “I believe it is safe for people 
to use stimulant medication in excess or for purposes other than prescribed by a physician” 
and “It is ethical for people without diagnosed ADHD to use stimulant medication for any 
reason.” The response scale ranged from 1 (Strongly Disagree) to 7 (Strongly Agree). 
 Subjective norms. Subjective norms were assessed with questions regarding social 
acceptability of use and perceptions of close others’ beliefs regarding NMUPS. Items were 
modeled after a sample TPB questionnaire (Ajzen, n.d.-a) and Judson and Langdon (2009). 
Sample items include: “I know at least one person (e.g., family member/friend/significant 
other) who misuses his/her own stimulant medication for the purpose of weight loss/appetite 
suppression” and “I believe the use of stimulant medication by people without diagnosed 
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ADHD, is common.” The response scale ranged from 1 (Strongly Disagree) to 7 (Strongly 
Agree). 
 Perceived behavioral control. Perceived behavioral control assessed participants’ 
perceptions of their ability to lose weight without the use of stimulants. Items were modeled 
after a sample TPB questionnaire (Ajzen, n.d.-a) and Judson and Langdon (2009). Sample 
items include: “I feel I do not need stimulant medication to help me lose weight/control my 
appetite” and “I am confident that I could get a stimulant medication from someone if I 
wanted to.” The response scale ranged from 1 (Strongly Disagree) to 7 (Strongly Agree). 
Disordered eating behaviors. The Eating Disorder Examination-Self-report 
Questionnaire (EDE-Q; Fairburn & Beglin, 1994), which has demonstrated validity in both 
men and women (Lavender, De Young, & Anderson, 2010; Rose, Vaewsorn, Rosselli-
Navarra, Wilson, & Weissman, 2013), was used to measure disordered eating behavior and 
attitudes. It assesses engagement in binge episodes and a range of compensatory behaviors, 
including self-induced vomiting, laxative use, excessive exercise, and dietary restraint within 
the past 28 days. A sample item includes: “On how many of the past 28 days, have you had a 
definite fear that you might gain weight?” The response scale for this particular item ranged 
from 0 (No days) to 6 (Every day). 
Healthy and unhealthy weight loss behaviors. Items from Neumark-Sztainer et al.’s 
(2011) Project EAT-III Survey, were used to assess both healthy (e.g., exercise, ate less 
sweets) and unhealthy weight loss behaviors (e.g., fasted, used diuretics) participants had 
engaged in over the past 12 months. An energy drink item was also added as an unhealthy 
weight loss behavior (Jeffers, Vatalaro-Hill, & Benotsch, 2014). The response scale ranged 
from 1 (Never) to 4 (On a regular basis). 
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 Body dissatisfaction. The Appearance Evaluation subscale of the Multidimensional 
Body Self-Relations Questionnaire (MBSRQ; Brown, Cash, & Mikulka, 1990) was used to 
assess body dissatisfaction. The MBSRQ is a 69-item questionnaire that assesses attitudes 
toward the body and body image, and has demonstrated validity in both men and women 
samples (Cash, Morrow, Hrabosky, & Perry, 2004). The Appearance Evaluation subscale (7 
items) assesses how satisfied one is with the appearance of one’s body. Sample items 
include: “I like my looks just the way they are” and “I am physically unattractive.” The 
response scale ranged from 1 (Definitely disagree) to 5 (Definitely agree). 
Media influence on body image. The Sociocultural Attitudes Towards Appearance 
Questionnaire-3 (SATAQ-3; Thompson, van den Berg, Roehrig, Guarda, & Heinberg, 2004) 
is a widely used, self-report questionnaire that assesses various sociocultural influences on 
body image and eating disturbances, and has demonstrated both reliability and validity in 
studies with women and men (Karazsia & Crowther, 2008). This measure has four subscales: 
the internalization of media, both generally and related to athleticism; pressures; and 
information. However, only the pressures subscale was used in the current study as it has 
previously been shown to account for significantly more variance in body dissatisfaction than 
the other three subscales (Thompson et al., 2004). The pressures subscale assesses perceived 
pressures from the media to achieve the sociocultural appearance ideal. A sample item 
includes: “I've felt pressure from TV or magazines to have a perfect body.” The response 
scale ranged from 1 (Definitely disagree) to 5 (Definitely agree).  
Depressive symptomatology. The Center for Epidemiologic Studies Depression 
Scale-Revised (CESD-R; Eaton, Muntaner, Smith, Tien, & Ybarra, 2004) was used to assess 
depressive symptomatology. This is a valid and reliable instrument that has wide 
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applicability in the general population (Van Dam & Earleywine, 2011). A sample item 
includes: “Nothing made me happy.” The response scale ranged from 0 (Not at all or less 
than 1 day) to 4 (Nearly every day for 2 weeks). 
Other substance use. Participants reported on other recreational drugs and 
substances used within the past year. Similar items have shown utility in prior work 
(Benotsch, Perschbacher Lance, Nettles, & Koester, 2012).   
Data Analysis 
 All data were analyzed using SPSS 22, except for the SEM analysis, which was 
conducted using Mplus version 7.31.  
First aim. The first aim of this study was to examine the prevalence of NMUPS for 
weight loss in a broader, national sample of young adults. Frequency rates were calculated to 
assess the number and percentage of participants who had ever engaged in NMUPS for 
weight loss (i.e., lifetime users). Additionally, lifetime frequency rates were calculated to 
assess the percentage of participants who had engaged in NMUPS for other motivations. The 
same frequency statistics were conducted to assess past year use.  
Second aim. The second aim of this study was to investigate correlates of NMUPS 
for weight loss, including negative consequences associated with this misuse, age of onset, 
factors influencing participants’ decision to use prescription stimulants for weight loss, 
knowledge about these medications, medication source, and perceived effectiveness of 
NMUPS for weight loss. Frequency statistics were used to calculate the types of negative 
consequences experienced, how individuals decided to try NMUPS for weight loss, amount 
of knowledge concerning the medication, medication source, and perceived effectiveness. 
Descriptive statistics (mean, range) were used to describe the age of onset for the behavior.  
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Third aim.  The third aim of this study was to evaluate the utility of the TPB model 
to predict membership in one of three groups: individuals who have engaged in NMUPS for 
weight loss in the past year; individuals who have tried to lose weight via other methods in 
the past year; and those who have not tried to lose weight in the past year. However, given 
that the outcome was multinomial (i.e., three weight loss groups), Mplus would not provide 
the desired fit statistics. Thus, to obtain fit statistics, participants who had not tried to lose 
weight in the past year were removed from the analysis as they had not endorsed one of the 
main variables of interest, and as such, are a less interesting group. A SEM with weighted 
least squares means and variance adjusted (WLSMV) estimation was conducted to examine 
the overall fit of attitudes toward NMUPS for weight loss; social norms regarding NMUPS 
for weight loss; and perceived behavioral control to lose weight without stimulants, as well 
as to obtain stimulant medication, as predictors of engaging in past year NMUPS for weight 
loss. 
SEM allows for the estimation of latent variables (e.g., attitudes) compared to 
observed variables only, thus eliminating random error (Hays, Revicki, & Coyne, 2005). 
SEM also allows comparisons between an observed variance/covariance matrix (i.e., the 
current data) and a hypothesized or implied variance/covariance matrix (i.e., TPB), to 
determine how well the theoretical model fits the given data. The chi-square test and the root 
mean square error of approximation (RMSEA) were used to assess the model fit. A p > .05 
for the chi-square test and a RMSEA < .06 were used to indicate a good model (Hu & 
Bentler, 1999; Tucker & Lewis, 1973). 
Questionnaire items related to the TPB were used as indicators to examine the latent 
constructs in the SEM. Because some of these items were developed for the current study (a 
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standard practice for TPB measures; Ajzen, n.d.-b), factor analysis was performed to test that 
items adequately fit their respective constructs and to remove any poorly fitting items prior to 
fitting the SEM. Further, examining the amount of predictive variance of each latent 
construct in the model allows for testing of the hypothesis for aim 3: Individuals who have 
engaged in NMUPS for weight loss will have more favorable attitudes toward the behavior 
(e.g., view the behavior as ethical), view the behavior as common, and have lower perceived 
behavioral control to lose weight without the help of stimulants, as well as higher perceived 
behavioral control to obtain stimulant medication compared to the other group.  
Fourth aim. The fourth aim of this study was to compare the three groups on 
additional relevant behaviors and constructs: disordered eating behaviors, body image, other 
substance use, and depressive symptomatology. A MANCOVA was conducted to compare 
the three groups on the following continuous dependent variables: body dissatisfaction, 
media influence on body image, eating attitudes, and depressive symptomatology. The 
following covariates were included: gender, age, race/ethnicity, educational status, and BMI. 
Although results have been inconsistent, NMUPS for weight loss has been associated with 
being White and having a lower BMI (Jeffers & Benotsch, 2014; Jeffers et al., 2013). Chi-
square analyses were also performed to compare the two weight loss groups on the following 
dichotomous outcomes: disordered eating behaviors and engagement in healthy and 
unhealthy weight loss behaviors. A chi-square analysis was also performed to compare the 
three groups on other substance use. Bonferroni post-hoc tests were conducted if significant 
differences were found between groups. Conducting the MANCOVA and chi-square 
analyses allowed for the testing of significant differences between group means, thus 
allowing for the testing of the hypothesis for aim 4: The three groups will differ on various 
	  30 
constructs, such that individuals who engage in NMUPS for weight loss will have poorer 
body image, higher rates of disordered eating, higher rates of other substance use, and greater 
depressive symptomatology compared to the other two groups. 
Results 
Descriptive Results 
 Data were collected from September 2014 thru February 2015. A total of 1856 
surveys were submitted on MTurk. Three-hundred and thirty entries were removed from 
analyses due to one of five reasons: the participant 1) was outside of the 18-25 year age range 
(or missing age; age range from 18-70 years), 2) voluntarily completed the survey twice, 3) 
incorrectly answered two or more of the quality assurance questions, 4) encountered a 
technical error where the same survey was submitted more than once, or 5) resided outside of 
the United States. See Table 1. (Participants who were outside of the age range or resided 
outside of the United States were allowed to complete the survey due to some errors with 
initial implementation of the MTurk survey.)  
Table 1.  
Reasons entries were deleted from MTurk. 
 
 
Reason Deleted 
 
 
n 
 
% 
 
Outside of Age Range (or Missing Age) 
 
177 
 
9.5 
 
Voluntarily Completed Survey Twice 
 
109 
 
5.9 
 
Quality Assurance Questions 
 
37 
 
2.0 
 
Duplicate Survey (Due to Technical Error) 
 
4 
 
0.22 
 
Location 
 
3 
 
0.16 
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n = 1856. 
 
 The total usable n = 1526. The mean age of the participants was 22.32 years (SD = 
2.05) and the sample consisted of 955 females (62.6%), 538 males (35.2%), and 33 
transgender (2.2%) individuals. The majority of the sample was White (74.4%), followed by 
African-American (8.5%), Hispanic/Latino (6.9%), Asian-American (6.7%), other 
race/ethnicity (2.6%), and Native American participants (0.9%). Participants’ BMI ranged 
from 12.75 to 68.52 (M = 26.07, SD = 7.24), indicating a slightly overweight sample. 
Approximately 17.0% of individuals reported having a high school diploma/GED or less than 
a high school education. The remaining 83.0% had completed at least one year of 
college/university or higher (e.g., had a four-year college degree). A plurality of participants 
reported a total household income of $0-25,999 (37.6%) for the previous year, followed by 
$26,000-51,999 (30.6%), more than $75,000 (12.9%), $52,000-74,999 (12.4%), and 6.5% 
reported that they “didn’t know/declined to say.” Approximately 15.0% of participants 
reported ever being prescribed a prescription stimulant medication by a doctor to treat 
ADHD. Based on data from the 2010 census (U.S. Census Bureau, 2014a), participants’ state 
residencies were highly representative of the U.S. population (r = .97, p < .001). To calculate 
this statistic, states were listed by population rank and then participant frequencies from the 
current dataset were entered to correspond with the state rankings. Next, a correlation was 
run between participant home states and the 2010 census data on state populations for the 
U.S. The state represented the most was California (n = 154) and the least represented state 
was Wyoming (n = 1). The majority of participants were from urban (72.5%) versus rural 
(27.5%) areas. 
First Aim  
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Approximately one-third (33.1%) of participants reported that they had ever engaged 
in NMUPS (n = 507), with 51.0% of these individuals reporting past year use (n = 258). Of 
those reporting lifetime NMUPS, 36.2% of participants reported engaging in NMUPS for 
weight loss (n = 184), or 12.1% of the total sample. Of those reporting NMUPS for weight 
loss, 48.4% reported past year use (n = 89). The top five reported motivations for engaging in 
NMUPS in one’s lifetime were: to increase concentration (77.4%), to increase energy 
(77.0%), as a study aid (72.3%), to increase alertness (67.5%), and to get high (57.0%). 
Weight loss was the twelfth most commonly-reported lifetime motivation. See Table 2. The 
top five reported motivations for past year NMUPS were: to increase concentration (73.7%), 
to increase energy (72.8%), to increase alertness (68.0%), as a study aid (66.0%), and to get 
high (53.1%). Weight loss was the eleventh most commonly-reported past year motivation. 
See Table 3. 
Table 2.  
Frequencies of NMUPS motivations—lifetime.  
NMUPS Motivation—
Lifetime n 
Percentage of Those 
Reporting NMUPS Percentage of Total n 
To increase concentration 393 77.4 25.8 
Increased energy 389 77.0 25.5 
Study aid 365 72.3 23.9 
Because it helps increase 
my alertness 
340 67.5 22.3 
To get high 289 57.0 18.9 
Because of 
experimentation 
286 56.9 18.7 
To try something new 274 54.0 18.0 
To reduce anxiety 262 52.1 17.2 
Pain relief 218 43.1 14.3 
Coping with a difficult 
problem 
203 40.2 13.3 
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NMUPS Motivation—
Lifetime n 
Percentage of Those 
Reporting NMUPS Percentage of Total n 
To forget my worries 197 39.4 12.9 
Weight loss/appetite 
suppression 
184 36.2 12.1 
To feel more self-
confident 
177 35.0 11.6 
To fit in and not be 
excluded 
104 20.8 6.8 
Because it’s safer than 
street drugs 
93 18.4 6.1 
Sexual stimulant 92 18.2 6.0 
Because it counteracts the 
effects of other drugs 
90 17.8 5.9 
Because I’m addicted 44 8.8 2.9 
 
Note. n ranges from 500-508.  
 
Table 3.  
Frequencies of NMUPS motivations—past year. 
 
NMUPS Motivation—
Past Year 
n 
Percentage of Those 
Reporting Past Year 
NMUPS 
Percentage of Total n 
To increase concentration 188 73.7 12.3 
Increased energy 185 72.8 12.1 
Because it helps increase 
my alertness 
172 68.0 11.3 
Study aid 167 66.0 10.9 
To get high 136 53.1 8.9 
To reduce anxiety 125 49.2 8.2 
To try something new 95 37.5 6.2 
Because of 
experimentation 
93 36.9 6.1 
Coping with a difficult 
problem 
93 36.8 6.1 
To feel more self-
confident 
92 36.5 6.0 
To forget my worries 91 35.8 6.0 
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NMUPS Motivation—
Past Year 
n 
Percentage of Those 
Reporting Past Year 
NMUPS 
Percentage of Total n 
Weight loss/appetite 
suppression 
89 35.2 5.8 
Pain relief 87 34.7 5.7 
Because it counteracts the 
effects of other drugs 
54 21.2 3.5 
Because it’s safer than 
street drugs 
51 20.1 3.3 
Sexual stimulant 47 18.6 3.1 
To fit in and not be 
excluded 
44 17.3 2.9 
Because I’m addicted 29 11.4 1.9 
 
Note. n ranges from 251-256.  
 
Second Aim  
Female (13.6%) and transgender participants (24.2%) were more likely than males 
(8.6%) to report engaging in NMUPS for weight loss, χ2(2) = 13.04, p = .001. White and 
non-White participants reported similar rates of the behavior with 12.6% of Whites reporting 
use and 10.5% of non-Whites reporting use, χ2(1) = 1.23, p = .268. Interestingly, there were 
significant differences in education, with 15.8% of participants with a high school 
diploma/GED or less than a high school education reporting use and 11.3% of participants 
who had completed at least one year of college/university or higher reporting use, χ2(1) = 
4.07, p = .044. Additionally, there were significant differences in age between participants 
reporting NMUPS for weight loss (M = 22.67, SD = 1.96) and those who did not (M = 22.28, 
SD = 2.06), t(1524) = -2.44, p = .015. There were also significant differences in BMI 
between participants reporting NMUPS for weight loss (MRank = 832.79; M = 26.78, SD = 
6.61) and those who did not (MRank = 749.97; M = 25.97, SD = 7.32), z = -2.40, p = .016. 
Additionally, there were slight regional differences among individuals reporting this 
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behavior: South—32.6%, Northeast—26.6%, West—21.7%, and Midwest—19.0%, with 
slightly higher rates in the South and Northeast regions. However, there was only a 
significant difference in reporting for the Northeast region, with 15.6% of individuals living 
in the Northeast region reporting use, compared with 11.1% of individuals living in other U.S. 
regions reporting use, χ2(1) = 4.69, p = .030. NMUPS for weight loss did not differ between 
participants residing in rural (11.0%) versus urban (12.5%) areas, χ2(1) = 0.68, p = .411. 
Participants reported that they started engaging in NMUPS for weight loss ranging 
from 12 to 24 years (M = 18.16, SD = 2.71). Around 8.5% of participants reported starting 
between the ages of 12-14 (approximate age during middle school), 33.4% reported starting 
between the ages of 15-17 (approximate age during high school), and 58.2% reported starting 
at age 18 and over. Participants also reported that they decided to try a prescription stimulant 
without a doctor’s orders specifically for the purpose of weight loss/appetite suppressive 
effects due to: knowing someone else who was doing it (48.9%), someone else giving his/her 
ADHD medication specifically for that purpose (23.4%), hearing about the idea from the 
media (e.g., TV, radio, Internet; 19.7%), and for other reasons not listed (8.0%). A vast 
majority of participants reported receiving their stimulant medications from friends (82.1%), 
followed by family (10.9%), the Internet (3.3%), a stranger (2.2%), and other sources (1.6%). 
Interestingly, one participant reported getting the medication from a “teenager whose house I 
was watching while they were away.” In terms of effectiveness, many participants reported 
that engaging in NMUPS for weight loss was “mildly effective” (43.1%), followed by “very 
effective” (21.3%), “somewhat effective” (18.1%), and “not at all effective” (17.6%).  
Individuals also reported a number of consequences associated with NMUPS for 
weight loss. The top five commonly-reported past year consequences were: enjoyed using 
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stimulants (54.3%), lost weight or not eaten properly (52.0%), felt bad physically (46.6%), 
felt guilty or ashamed (38.8%), and done impulsive things you later regretted (38.3%). See 
Table 4. The top five commonly-reported consequences experienced in one’s lifetime, but 
not in the past year, were: lost weight or not eaten properly (33.9%), enjoyed using 
stimulants (33.0%), taken drugs in larger amounts or over a longer period of time than 
planned (27.2%), felt bad physically (27.1%), and done impulsive things you later regretted 
(26.9%). See Table 5.  
Table 4.  
 
Frequencies of negative consequences associated with NMUPS for weight loss—past year 
consequences. 
 
Negative Consequences—Past 
Year n 
Percentage of Those Reporting 
NMUPS for Weight Loss 
Enjoyed using drugs 99 54.3 
Lost weight or not eaten properly 
because of my stimulant use 
95 52.0 
Felt bad physically 84 46.6 
Felt guilty or ashamed 71 38.8 
Done impulsive things you later 
regretted 
70 38.3 
Spent too much money or lost a lot 
of money 
68 37.2 
Spent a significant amount of time 
thinking about, looking for, or 
using 
67 36.6 
Taken drugs in larger amounts or 
over longer period of time than 
you planned 
67 36.3 
Need more drugs to get the same 
effect or don’t get the same effect 
with the usual amount 
66 36.1 
Wanted or tried to limit, cut down, 
or stop 
62 33.7 
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Negative Consequences—Past 
Year n 
Percentage of Those Reporting 
NMUPS for Weight Loss 
Failed to do what was expected of 
you 
61 33.5 
Been unhappy because of my 
stimulant use 
59 32.8 
Lost interest in activities or 
hobbies 
59 32.0 
Missed school, work, or activities 
with friends 
56 30.6 
Said or done something 
embarrassing 
53 29.0 
Continued to use despite 
psychological or physical 
consequence 
50 27.4 
Performed poorly at school or 
work 
46 25.0 
While using stimulants I said 
harsh or cruel things to someone 
45 24.9 
Take more to avoid or reduce 
withdrawal 
41 22.2 
My personality has changed for 
the worse 
32 17.4 
Needed medical treatment 23 12.5 
Gotten into a physical fight 22 11.9 
Lost a close relationship 22 11.9 
Gotten into legal trouble or 
arrested 
21 11.7 
Had to go to the Emergency Room 
(ER) 
18 9.7 
Been suspended, expelled from 
school, or fired from work 
14 7.5 
 
Note. n ranges from 181-184.  
 
Table 5.  
Frequencies of negative consequences associated with NMUPS for weight loss—lifetime but 
not past year consequences. 
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Negative Consequences—
Lifetime But Not Past Year n 
Percentage of Those Reporting 
NMUPS for Weight Loss 
Lost weight or not eaten properly 
because of my stimulant use 
62 33.9 
Enjoyed using drugs 60 33.0 
Taken drugs in larger amounts or 
over longer period of time than 
you planned 
50 27.2 
Felt bad physically 49 27.1 
Done impulsive things you later 
regretted 
49 26.9 
Said or done something 
embarrassing 
49 26.8 
Felt guilty or ashamed 48 26.4 
Been unhappy because of my 
stimulant use 
46 25.6 
Need more drugs to get the same 
effect or don’t get the same effect 
with the usual amount 
45 24.6 
Lost a close relationship 44 24.2 
My personality has changed for 
the worse 
44 23.9 
Continued to use despite 
psychological or physical 
consequence 
43 23.5 
Spent a significant amount of time 
thinking about, looking for, or 
using 
42 23.0 
Wanted or tried to limit, cut down, 
or stop 
42 22.8 
Failed to do what was expected of 
you 
41 22.5 
Spent too much money or lost a lot 
of money 
39 21.4 
While using stimulants I said 
harsh or cruel things to someone 
38 21.0 
Missed school, work, or activities 
with friends 
36 19.7 
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Negative Consequences—
Lifetime But Not Past Year n 
Percentage of Those Reporting 
NMUPS for Weight Loss 
Lost interest in activities or 
hobbies 
35 19.0 
Performed poorly at school or 
work 
32 17.5 
Take more to avoid or reduce 
withdrawal 
32 17.4 
Gotten into a physical fight 27 14.7 
Been suspended, expelled from 
school, or fired from work 
24 13.2 
Had to go to the Emergency Room 
(ER) 
20 10.9 
Gotten into legal trouble or 
arrested 
19 10.5 
Needed medical treatment 15 8.2 
 
Note. n ranges from 181-184. 
Individuals also answered questions concerning their knowledge of stimulant 
medications. On a scale from “Strongly Disagree” to “Strongly Agree,” 76.5% of participants 
reported that they agreed or strongly agreed with the statement: “I consider myself to be 
knowledgeable about the side effects associated with the use of stimulant medication 
normally used to treat ADHD (e.g., Adderall, Ritalin, Vyvanse).” See Table 6. The greatest 
sources of exposure to information about side effects associated with the use of ADHD 
medication include: the Internet (73.9%), other students/friends (46.7%), and in class 
(33.7%). See Table 7. When presented with symptoms that either were or were not side 
effects, the top five items that were answered correctly were: nighttime wakefulness 
(insomnia) and reductions in appetite with 90.7% of individuals answering both correctly, 
increase in heart rate (85.8%), dry mouth (73.9%), headache and anxiety with 72.3% of 
participants answering both correctly, and tachycardia (excessively rapid heartbeat; 70.1%). 
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The total mean score of side effects that were answered correctly was M = 60.33%. There 
was a moderate correlation between participants’ confidence in their knowledge about side 
effects and their actual knowledge (r = .28, p < .001). See Table 8. When presented with both 
true and false contraindications, the top five items that were answered correctly were: history 
of drug abuse (82.1%), serious cardiac (heart) problems (76.4%), during or within 14 days 
following MAOI (antidepressant medication) use (49.5%), hyperthyroidism (43.5%), and 
influenza (35.0%). The total mean score of contraindications that were answered correctly 
was M = 42.88%. See Table 9. 
Table 6.  
Extent to which individuals consider themselves knowledgeable about side effects of 
stimulant medications (of those reporting NMUPS for weight loss). 
 
 
Knowledgeable of Side Effects 
 
	  
n	  
 
Percentage 
 
Strongly Disagree 
 
7 
 
3.8 
 
Disagree 21 11.4 
 
Neither 15 18.2 
 
Agree 90 49.2 
 
Strongly Agree 50 27.3 
 
 
n = 183. 
 
Table 7.  
Frequencies— sources of exposure to information about side effects associated with use of 
ADHD medication (of those reporting NMUPS for weight loss). 
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Source 
 
 
n 
 
 
Percentage 
 
 
Internet 
 
136 
 
73.9 
 
Other students/friends 
 
86 46.7 
In class 
 
62 33.7 
Healthcare facility pamphlet 
 
45 24.5 
Television 
 
40 21.7 
Books 
 
24 13.0 
None 
 
21 11.4 
Parents 
 
20 10.9 
Magazine 
 
18 9.8 
Other 
 
15 8.2 
Information session 
 
11 6.0 
 
n = 184. 
 
Table 8.  
Frequencies—knowledge about medication: Side effects (of those reporting NMUPS for 
weight loss). 
 
Side Effect Correct (n; 
percentage) 
 
Incorrect (n; 
percentage) 
Don’t Know (n; 
percentage) 
Nighttime 
wakefulness 
(insomnia) 
166 (90.7) 12 (6.6) 5 (2.7) 
Reductions in 
appetite 
166 (90.7) 10 (5.5) 7 (3.8) 
Increase in heart 
rate 
157 (85.8) 15 (8.2) 11 (6.0) 
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Side Effect Correct (n; 
percentage) 
 
Incorrect (n; 
percentage) 
Don’t Know (n; 
percentage) 
Dry mouth 136 (73.9) 22 (12.0) 26 (14.1) 
Headache 133 (72.3) 28 (15.2) 23 (12.5) 
Anxiety 133 (72.3) 31 (16.8) 20 (10.9) 
Tachycardia 
(excessively rapid 
heartbeat) 
129 (70.1) 38 (20.7) 17 (9.2) 
Agitation 124 (67.4) 39 (21.2) 21 (11.4) 
Increase in blood 
pressure 
123 (67.2) 29 (15.8) 31 (16.9) 
Dizziness 111 (60.7) 46 (25.1) 26 (14.2) 
Adverse psychiatric 
problems 
107 (58.2) 41 (22.3) 36 (19.6) 
Cardiovascular 
adverse reactions 
99 (54.1) 47 (25.7) 37 (20.2) 
Sore throat 93 (50.5) 33 (17.9) 58 (31.5) 
Vomiting 78 (42.6) 62 (33.9) 43 (23.5) 
Abdominal pain 78 (42.4) 63 (34.2) 43 (23.4) 
Diarrhea 58 (31.5) 72 (39.1) 54 (29.3) 
Sudden death 52 (28.4) 84 (45.9) 47 (25.7) 
Nausea 51 (27.9) 102 (55.7) 30 (16.4) 
 
Note. n ranges from 183-184. Items listed in italics are possible side effects. 
 
Table 9.  
Frequencies—knowledge about medication: Contraindications (of those reporting NMUPS 
for weight loss). 
 
Contraindication Correct (n; 
percentage) 
 
Incorrect (n; 
percentage) 
Don’t Know (n; 
percentage) 
History of drug abuse 151 (82.1) 16 (8.7) 17 (19.2) 
Serious cardiac 
(heart) problems 
139 (76.4) 22 (12.1) 21 (11.5) 
During or within 14 
days following MAOI 
(antidepressant 
medication) use 
91 (49.5) 24 (13.0) 69 (37.5) 
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Contraindication Correct (n; 
percentage) 
 
Incorrect (n; 
percentage) 
Don’t Know (n; 
percentage) 
Hyperthyroidism 80 (43.5) 31 (16.8) 73 (39.7) 
Influenza 64 (35.0) 26 (14.2) 93 (50.8) 
Crohn’s disease 39 (21.3) 35 (19.1) 109 (59.6) 
Migraines 36 (19.7) 68 (37.2) 79 (43.2) 
Glaucoma 33 (18.1) 53 (29.1) 96 (52.7) 
 
Note. n ranges from 182-184. Items listed in italics are possible contraindications. 
 
Third Aim  
Factor analysis was performed to test that questionnaire items related to the TPB 
adequately fit their respective constructs and to remove any poorly fitting items. The 
extraction technique performed in this study was principal axis factoring, and promax 
rotation was utilized as the rotation technique given that factors were expected to correlate. 
To determine the number of factors to be retained, the Guttman-Kaiser rule (i.e., retain 
factors with an eigenvalue larger than 1), scree plots, percentage of variance accounted for by 
the factors, and congruency of items with the theory were considered.  
The attitudes construct loaded onto three separate factors with an eigenvalue ≥ 1. The 
first factor included five indicators of attitudes [eigenvalue = 4.33, R2 = .48; α = .88]. The 
second factor included two indicators of attitudes [eigenvalue = 1.37, R2 = .15; α = .86]. 
Finally, the third factor included two indicators of attitudes [eigenvalue = 1.28, R2 = .14; α 
= .84]. See Table 10 for the factor loadings of these items. 
Table 10.  
Factor loadings for the attitudes items. 
Attitude Items Factor 
Loading 
(Factor 1) 
 
Factor 
Loading 
(Factor 2) 
 
Factor 
Loading 
(Factor 3) 
 
Mean (SD) 
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Attitude Items Factor 
Loading 
(Factor 1) 
 
Factor 
Loading 
(Factor 2) 
 
Factor 
Loading 
(Factor 3) 
 
Mean (SD) 
1. It is ethical for people 
without diagnosed ADHD 
to use stimulant medication 
for any reason. 
 
.739 -.051 .002 2.91 (1.68) 
2. It is ethical for people 
diagnosed with ADHD to 
use stimulant medication in 
excess or for purposes other 
than prescribed by a 
physician. 
 
.764 .068 .014 2.65 
(1.596) 
3. It is ethical for people 
with diagnosed ADHD to 
use stimulant medication to 
lose weight/control 
appetite. 
 
.892 -.043 -.058 2.84 (1.64) 
4. It is ethical for people 
without diagnosed ADHD 
to use stimulant medication 
to lose weight/control 
appetite. 
 
.886 -.045 -.021 2.67 (1.67) 
5. I believe it is safe for 
people to use stimulant 
medication in excess or for 
purposes other than 
prescribed by a physician. 
 
.523 .188 .148 2.17 (1.48) 
6. I am concerned that 
taking stimulant medication 
in excess or for purposes 
other than prescribed by a 
physician will adversely 
affect a person’s health. 
 
-.063 1.022 -.011 5.46 (1.46) 
	  45 
Attitude Items Factor 
Loading 
(Factor 1) 
 
Factor 
Loading 
(Factor 2) 
 
Factor 
Loading 
(Factor 3) 
 
Mean (SD) 
7. I am concerned that 
taking stimulant medication 
to lose weight/control 
appetite will adversely 
affect a person’s health. 
 
.060 .746 -.022 5.38 (1.47) 
8. I feel that the benefits of 
using a prescription 
stimulant medication 
without a doctor’s orders 
for any reason outweigh the 
potential risks. 
 
-.020 -.017 .878 3.10 (1.86) 
9. I feel that the benefits of 
someone misusing their 
own prescription stimulant 
medication for any reason 
outweigh the potential risks. 
 
.013 -.016 .846 3.02 (1.84) 
 
n = 1422. 
 
 Similarly, a factor analysis was performed on the subjective norms items, and four 
separate factors emerged with an eigenvalue ≥ 1. The first factor included four indicators of 
subjective norms [eigenvalue = 3.18, R2 = .32; α = .83]. The second factor included two 
indicators of subjective norms [eigenvalue = 2.02, R2 = .20; α = .95]. The third factor 
included two indicators of subjective norms [eigenvalue = 1.47, R2 = .15; α = .85]. Finally, 
the fourth factor also included two indicators of subjective norms [eigenvalue = 1.396, R2 
= .14; α = .80]. See Table 11 for the factor loadings of these items. 
Table 11.  
Factor loadings for the subjective norms items. 
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Subjective Norms Items Factor 
Loading 
(Factor 1) 
 
Factor 
Loading 
(Factor 2) 
Factor 
Loading 
(Factor 3) 
Factor 
Loading 
(Factor 4) 
Mean 
(SD) 
1. It is socially acceptable 
for people without 
diagnosed ADHD to use 
stimulant medication for 
any reason. 
 
.790 .079 -.130 .123 3.50 (1.78) 
2. It is socially acceptable 
for people diagnosed with 
ADHD to use stimulant 
medication in excess or 
for purposes other than 
prescribed by a physician. 
 
.789 .066 -.094 .081 3.37 (1.74) 
3. My 
friends/family/significant 
other believe that it is ok 
for people without 
diagnosed ADHD to use 
stimulant medication for 
any reason. 
.711 -.071 .122 -.083 2.98 (1.74) 
4. My 
friends/family/significant 
other believe that it is ok 
for people diagnosed with 
ADHD to use medication 
in excess or for purposes 
other than prescribed. 
 
.688 -.093 .156 -.139 2.88 (1.67) 
5. I know at least one 
person (e.g., family 
member/friend/significant 
other) who uses stimulant 
medications for the 
purpose of weight 
loss/appetite suppression 
without a doctor’s 
prescription. 
 
-.026 .033 .851 .057 3.28 (2.21) 
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Subjective Norms Items Factor 
Loading 
(Factor 1) 
 
Factor 
Loading 
(Factor 2) 
Factor 
Loading 
(Factor 3) 
Factor 
Loading 
(Factor 4) 
Mean 
(SD) 
6. I know at least one 
person (e.g., family 
member/friend/significant 
other) who misuses his/her 
own stimulant medication 
for the purpose of weight 
loss/appetite suppression. 
 
.029 .017 .834 .014 3.09 (2.11) 
7. I value my friends’/ 
family’s/significant 
other’s opinion on 
whether or not it is ok for 
people with a prescription 
to use the stimulant 
medication in excess or 
for purposes other than 
prescribed. 
 
.014 .947 .024 -.021 4.53 (1.69) 
8. I value my friends’/ 
family’s/significant 
other’s opinion on 
whether or not it is ok for 
people without a 
prescription to use the 
stimulant medication for 
any reason. 
 
-.012 .954 .020 -.018 4.499 
(1.695) 
9. I believe the use of 
stimulant medication by 
people without diagnosed 
ADHD, is common. 
 
.014 -.024 -.016 .841 5.33 (1.46) 
10. I believe the use of 
stimulant medication by 
people diagnosed with 
ADHD in excess or for 
purposes other than 
prescribed, is common. 
 
-.011 -.021 .092 .768 5.01 (1.46) 
 
n = 1411. 
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Finally, a factor analysis was performed on the perceived behavioral control items, 
and two separate factors emerged with an eigenvalue ≥ 1. The first factor included two 
indicators of perceived behavioral control [eigenvalue = 1.87, R2 = .47; α = .90]. The second 
factor also included two indicators of perceived behavioral control [eigenvalue = 1.62, R2 
= .41; α = .80]. See Table 12 for the factor loadings of these items. See Table 13 for means 
and standard deviations of each latent construct. 
Table 12.  
Factor loadings for the perceived behavioral control items. 
Perceived Behavioral Control Items Factor 
Loading 
(Factor 1) 
Factor 
Loading 
(Factor 2) 
 
Mean 
(SD) 
1. I feel I do not need stimulant medication 
to help me lose weight/control my appetite. 
 
-.033 -.819 5.70 (1.71) 
2. I am confident that I could get a stimulant 
medication from someone if I wanted to. 
 
-.905 .019 4.89 (1.93) 
3. I feel I could lose weight successfully 
without the help of a stimulant medication. 
 
.034 -.812 5.74 (1.60) 
4. I know people that would give/sell me a 
prescription stimulant medication if I wanted 
it.   
 
-.913 -.018 4.71 (2.09) 
 
n = 1504. 
Table 13.  
Means and standard deviations of the separate factors of the latent constructs. 
 
Construct 
 
Factor 
 
Mean (SD) 
 
 
Attitudes 
 
 
1 
 
13.25 (6.66) 
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Construct 
 
Factor 
 
Mean (SD) 
 
2 
 
5.16 (2.76) 
3 
 
6.16 (3.45) 
Subjective Norms 1 12.70 (5.63) 
2 8.99 (3.31) 
3 6.38 (4.03) 
4 10.31 (2.70) 
Perceived Behavioral Control 1 9.56 (3.85) 
2 4.55 (3.02) 
 
Note. n ranges from 1458-1519. 
Structural equation modeling. The third aim of this study was to examine NMUPS 
for weight loss and how this behavior relates to TPB constructs (latent variables), as well as 
to use this model to predict membership in one of two groups: individuals who have engaged 
in NMUPS for weight loss in the past year and individuals who have tried to lose weight via 
other methods in the past year. Thus, the dependent variable for the SEM consisted of two 
groups: 1) those reporting past year NMUPS for weight loss (and possibly other weight loss 
behaviors; n = 89), and 2) those reporting trying to lose weight via other methods (and not 
endorsing NMUPS for weight loss; n = 1340) in the past year. See Table 14 for frequencies 
of four possible weight loss groups. 
Table 14.  
Original frequencies of weight loss behavior groups (past year). 
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Weight Loss Behavior Group 
 
n 
 
% 
 
 
No Weight Loss Behaviors 
 
97 
 
6.4 
 
Other Weight Loss Behaviors, But No NMUPS 
 
1340 
 
87.8 
 
No Other Weight Loss Behaviors, NMUPS Only 
 
1 
 
0.1 
 
Other Weight Loss Behaviors and NMUPS 
 
88 
 
5.8 
 
 
n = 1526. 
A SEM with WLSMV estimation was conducted to examine the overall fit of 
attitudes toward NMUPS for weight loss; social norms regarding NMUPS for weight loss; 
and perceived behavioral control to lose weight without stimulants, as well as to obtain 
stimulant medication, as predictors of engaging in past year NMUPS for weight loss. 
Separate latent constructs were estimated for each of the TPB constructs, and were 
correlated with each other in the final model. The model provided adequate overall fit to the 
data (χ2 = 1273.88, df = 208, p < .001, RMSEA = .058 [90% CI = .055, .061]). Indeed, two of 
the four subjective norms factors were significantly associated with NMUPS for weight loss, 
indicating that those with greater subjective norms regarding knowing at least one person 
who uses stimulant medication for the purpose of weight loss/appetite suppression (β = .272, 
p < .001), in addition to believing that NMUPS is common (β = .196, p < .05) were more 
likely to report NMUPS for weight loss. Further, both perceived behavioral control factors 
were significantly associated with NMUPS for weight loss, indicating that those with lower 
perceived behavioral control such that they were less likely to feel that they could lose 
weight without the help of a stimulant medication (β = -.322, p < .001), as well as feeling 
confident that they could obtain a stimulant medication from someone if they wanted to (β 
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= .172, p < .05) were more likely to report NMUPS for weight loss. Results from the SEM 
are presented in Figure 1. Additionally, the model indicated many significant correlations 
among the separate factors of the three latent predictors of NMUPS. See Table 15 for 
correlations. 
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Figure 1. Results for the structural equation model. χ2 (208) = 1273.88, p < .001. Root Mean 
Square Error of Approximation = .058. Note. All coefficients are standardized. Also, *p-
value < .001. Dotted line = not significant. Att = Attitudes. SN = Subjective Norms. PBC = 
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Perceived Behavioral Control. The construct followed by an underscore and number 
represents the factor number for that construct. 
 
Table 15.  
Correlations among the separate factors of the latent constructs.  
Latent 
Construct 
Att_1 Att_2 Att_3 Norms
_1 
Norms_2 Norms_3 Norms_4 PBC_1 PBC_2 
 
Att_1 
 
1 
        
Att_2 -.39** 1        
Att_3 .41** -.22** 1       
Norms_1 .49** -.21** .28** 1      
Norms_2 -.02 .13** -.01 -.03 1     
Norms_3 .23** -.14** .16** .31** .02 1    
Norms_4 .00 .33** .04 .21** .09** .15** 1   
PBC_1 .13** .01 .13** .32** .02 .32** .36** 1  
PBC_2 -.28** .38** -.19** -.16** .12** -.24** .14** .05* 1 
 
Note. n ranges from 1411-1519. ** p < .001. * p < .05. Att = Attitudes. PBC = Perceived 
Behavioral Control. The construct followed by an underscore and number represents the 
factor number for that construct. 
 
 There were significant correlations among the three attitude factors, indicating that 
those who were more likely to feel that engaging in NMUPS is ethical and safe were less 
likely to be concerned that NMUPS would adversely affect a person’s health (r = -.39, p 
< .001), in addition to feeling the benefits of NMUPS outweigh the potential risk (r = .41, p 
< .001). Further, those who were less likely to be concerned that NMUPS would adversely 
affect a person’s health were more likely to feel the benefits of NMUPS outweigh the 
potential risk (r = -.22, p < .001).  
 There were also many significant correlations among the four subjective norms 
factors, indicating that those who perceived greater social acceptability toward NMUPS were 
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more likely to know at least one person who engages in NMUPS for the purpose of weight 
loss/appetite suppression (r = .31, p < .001), in addition to believing NMUPS is common (r 
= .21, p < .001). Those who were more likely to know at least one person who engages in 
NMUPS for the purpose of weight loss/appetite suppression were also more likely to believe 
NMUPS is common (r = .15, p < .001). Finally, those who were more likely to value their 
friends’/ family’s / significant other’s opinion on whether or not it is okay for people to 
engage in NMUPS were more likely to believe NMUPS is common (r = .09, p < .001). 
 There was also a significant correlation between the two PBC factors, indicating that 
those who were more likely to feel that they could lose weight without the help of a stimulant 
medication were also more likely to feel that they could obtain a stimulant medication if they 
wanted to (r = .05, p < .05). 
 Further, there were many significant correlations among the separate factors of the 
latent constructs. Those who were more likely to feel that engaging in NMUPS is ethical and 
safe were also more likely to perceive greater social acceptability toward NMUPS (r = .49, p 
< .001), in addition to knowing at least one person who engages in NMUPS for the purpose 
of weight loss/appetite suppression (r = .23, p < .001). Those who were more likely to feel 
that engaging in NMUPS is ethical and safe were less likely to feel that they could lose 
weight without the help of a stimulant medication (r = -.28, p < .001), in addition to feeling 
that they could obtain a stimulant medication if they wanted to (r = .13, p < .001). 
 Those who were less likely to be concerned that NMUPS would adversely affect a 
person’s health were more likely to perceive greater social acceptability toward NMUPS (r = 
-.21, p < .001), in addition to knowing at least one person who engages in NMUPS for the 
purpose of weight loss/appetite suppression (r = -.14, p < .001). Further, those who were 
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more likely to be concerned that NMUPS would adversely affect a person’s health were more 
likely to value their friends’/ family’s / significant other’s opinion on whether or not it is 
okay for people to engage in NMUPS (r = .13, p < .001), in addition to believing NMUPS is 
common (r = .33, p < .001). Finally, those who were more likely to be concerned that 
NMUPS would adversely affect a person’s health were more likely to feel that they could 
lose weight successfully without the help of a stimulant medication (r = .38, p < .001). 
 Those who were more likely to feel the benefits of NMUPS outweigh the potential 
risks were also more likely to perceive greater social acceptability toward NMUPS (r = .28, p 
< .001), in addition to knowing at least one person who engages in NMUPS for the purpose 
of weight loss/appetite suppression (r = .16, p < .001). Further, those who were more likely 
to feel the benefits of NMUPS outweigh the potential risks were less likely to feel that they 
could lose weight successfully without the help of a stimulant medication (r = -.19, p < .001), 
and were more confident in feeling that they could obtain a stimulant medication if they 
wanted to (r = .13, p < .001). 
Those who were more likely to perceive greater social acceptability toward NMUPS 
were less likely to feel that they could lose weight without the help of a stimulant medication 
(r = -.16, p < .001), in addition to feeling more confident in feeling that they could obtain a 
stimulant medication if they wanted to (r = .32, p < .001). 
Additionally, those who were more likely to know at least one person who engages in 
NMUPS for the purpose of weight loss/appetite suppression were less likely to feel that they 
could lose weight without the help of a stimulant medication (r = -.24, p < .001), in addition 
to feeling more confident in feeling that they could obtain a stimulant medication if they 
wanted to (r = .32, p < .001). 
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Those who were more likely to value their friends’/ family’s / significant other’s 
opinion on whether or not it is okay for people to engage in NMUPS were more likely to feel 
that they could lose weight without the help of a stimulant medication (r = .12, p < .001). 
Those who were more likely to believe NMUPS is common were also more likely to 
feel that they could lose weight without the help of a stimulant medication (r = .14, p < .001), 
in addition to feeling more confident in feeling that they could obtain a stimulant medication 
if they wanted to (r = .36, p < .001). 
Fourth Aim  
The MANCOVA showed a significant main effect of the three weight loss groups on 
body dissatisfaction (α = .92), media influence on body image (α = .94), eating attitudes (α 
= .95), and depressive symptomatology (α = .96), Pillai’s trace = .13, F (8, 2630) = 23.45, p 
< .001, after controlling for gender, age, ethnicity, BMI, and education. Post hoc (Bonferroni) 
analyses showed that the NMUPS/weight loss group had greater body dissatisfaction (M = 
17.196, SE = .72) than both the weight loss/no NMUPS group (M = 20.94, SE = .18) and no 
weight loss group (M = 24.22, SE = .68; p < .001, p < .001, respectively). (Note that lower 
scores on this body image measure indicate less body satisfaction.) Similarly, the 
NMUPS/weight loss group felt greater pressure from the media to have an ideal body image 
(M = 24.61, SE = .89) than both the weight loss/no NMUPS group (M = 20.66, SE = .23) and 
no weight loss group (M = 15.75, SE = .84; p < .001, p < .001, respectively). The 
NMUPS/weight loss group had poorer eating attitudes and more eating disorder 
symptomatology (M = 3.28, SE = .14) than both the weight loss/no NMUPS group (M = 1.91, 
SE = .04) and no weight loss group (M = .65, SE = .14; p < .001, p < .001, respectively). 
Additionally, the NMUPS/weight loss group also exhibited greater depressive 
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symptomatology (M = 33.16, SE = 1.81) than both the weight loss/no NMUPS group (M = 
20.85, SE = .47) and no weight loss group (M = 17.25, SE = 1.71; p < .001, p < .001, 
respectively). Finally, the three groups each significantly differed from one another on each 
of the constructs mentioned above except that both the weight loss/no NMUPS group and no 
weight loss group reported similar rates of depressive symptomatology. See Table 16. 
Table 16.  
Three weight loss groups and MANCOVA constructs. 
MANCOVA 
Construct 
Individuals 
reporting 
NMUPS/other 
weight loss 
methods (n = 77): 
Mean (SE)  
Individuals 
reporting weight 
loss methods/no 
NMUPS (n = 
1159): Mean (SE)  
 
Individuals 
reporting no 
weight loss 
methods (n = 89): 
Mean (SE)  
p 
Body Dissatisfaction 17.196 (SE = .72)a 20.94 (SE = .18)b 24.22 (SE = .68)c < .001 
Media Influence on 
Body Image 
 
24.61 (SE = .89)a 20.66 (SE = .23)b 15.75 (SE = .84)c < .001 
Eating Attitudes 3.28 (SE = .14)a 1.91 (SE = .04)b .65 (SE = .14)c < .001 
Depressive 
Symptomatology 
 
33.16 (SE = 1.81)a 20.85 (SE = .47)b 17.25 (SE = 1.71)b < .001 
 
Note. n = 1325. Lower scores on the body dissatisfaction measure indicate less body 
satisfaction. Different subscript letters represent values that are significantly different.  
 
Chi-square analyses were also performed to compare the three weight loss groups on 
the following disordered eating behaviors: binge eating, vomiting, laxative use, excessive 
exercising, and dietary restraint. Frequency of behaviors was categorized as either regular 
occurrence (at least four times [i.e., weekly] in the past 28 days) or less than regular (no 
occurrence or less than four times in the last 28 days). Approximately 50.0% of individuals 
in the NMUPS/weight loss group reported regular binge eating episodes compared to 26.9% 
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in the weight loss/no NMUPS group and 4.1% in the no weight loss group, χ2(2) = 48.75, p 
< .001. Regular vomiting episodes also differed between the NMUPS/weight loss group 
(21.3%) and the weight loss/no NMUPS group (3.7%) and the no weight loss group (1.0%), 
χ2(2) = 63.43, p < .001; however, the latter two groups were not significantly different from 
one another. Similarly, the NMUPS/weight loss group reported more laxative episodes 
(13.5%) than the weight loss/no NMUPS group (3.3%) and the no weight loss group (1.0%), 
χ2(2) = 26.25, p < .001; again, the latter two groups were not significantly different from one 
another. For excessive exercise, regular occurrence was defined as “exercising in a driven or 
compulsive way— as a means of controlling weight, shape or amount of fat, or to burn off 
calories” at least 20 times over the past 28 days. The NMUPS/weight loss group were more 
likely to report excessive exercise episodes (13.5%) than the weight loss/no NMUPS group 
(5.5%) and the no weight loss group (0.0%), χ2(2) = 16.13, p < .001; the latter two groups 
were not significantly different. For dietary restraint, regular occurrence was defined as 
“going for long periods of time (eight hours or more) without eating anything to influence 
shape or weight” greater than 12 times over the past 28 days. All three weight loss groups 
were significantly different from one another, with 40.4% of the NMUPS/weight loss group 
reporting regular dietary restraint, 11.3% of the weight loss/no NMUPS group reporting 
restraint, and 2.1% of the no weight loss group reporting restraint, χ2(2) = 75.66, p < .001. 
See Table 17. 
Table 17.  
Three weight loss groups and disordered eating behaviors. 
	  59 
Disordered Eating 
Behavior 
Individuals 
reporting 
NMUPS/other 
weight loss 
methods (n = 
89) % reporting:  
 
Individuals 
reporting 
weight loss 
methods/no 
NMUPS (n = 
1340) % 
reporting:  
Individuals 
reporting no 
weight loss 
methods (n = 
97) % 
reporting:  
 
χ2 
Binge Eating 49.4a 26.9b 4.1c 48.75*** 
Vomiting 21.3a 3.7b 1.0b 63.43*** 
Laxative Use 13.5a 3.3b 1.0b 26.25*** 
Excessive 
Exercising 
 
13.5a 5.5b 0.0b 16.13*** 
Dietary Restraint 40.4a 11.3b 2.1c 75.66*** 
 
Note. n = 1526. Different subscript letters represent values that are significantly different. 
*** p < .001. 
 
 Chi-square analyses were also performed on the two weight loss groups to compare 
differences in the engagement of other unhealthy and healthy weight loss behaviors. The no 
weight loss group was excluded from these analyses (as with the SEM) given that 
participants in this group reported never engaging in any of the assessed weight loss 
behaviors. Because some of the variables had greater than acceptable skewness and kurtosis 
scores, the PI dichotomized the weight loss behaviors into “Never Engaged” for participants 
who never engaged in the behavior in the past year, and “Yes Engaged” for participants 
reporting having engaged in the behavior at least rarely in the past year (i.e., “rarely” to “on a 
regular basis”). The NMUPS/weight loss group had greater reporting of many of the 
behaviors compared to the weight loss/no NMUPS group, including: fasting, use of diet pills, 
diuretic use, using food substitutions (e.g., powder, special drink), skipping meals, smoking 
cigarettes for appetite control, and watching portion sizes. See Table 18. 
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Table 18.  
Two weight loss groups and unhealthy and healthy weight loss behaviors—past year.  
Weight Loss Behavior Individuals reporting 
NMUPS/other weight 
loss methods (n = 
89) % reporting:  
 
Individuals reporting 
weight loss methods/no 
NMUPS (n = 1340) % 
reporting:  
 
χ2 
Unhealthy Behaviors 
Ate very little food 95.5 74.4 19.896*** 
Skipped meals 86.4 61.4 21.99*** 
Fasted 83.0 41.3 58.19*** 
Smoked more cigarettes 69.7 20.4 112.90*** 
Took diet pills 67.0 19.1 110.66*** 
Drank energy drinks 
(e.g., Red Bull, Monster) 
62.9 33.9 30.68*** 
Used food substitute 
(powder/special drink) 
60.9 34.7 24.31*** 
Followed a high 
protein/low carbohydrate 
diet (e.g., Atkins or other) 
56.8 32.8 21.12*** 
Used diuretics (water 
pills) 
34.8 8.0 68.33*** 
Healthy Behaviors 
Exercise 95.5 93.5 .54, ns 
Ate less high-fat foods 92.0 84.9 3.33, ns 
Ate more fruits and 
vegetables 
91.0 91.3 .01, ns 
Watched my portion sizes 
(serving sizes) 
89.9 81.1 4.30* 
Ate less sweets 87.5 85.2 .36, ns 
Drank less soda pop (not 
including diet soda) 
83.1 80.8 .289, ns 
 
Note. n ranges from 1410-1427. ns = not significant. * p < .05, *** p < .001. 
 Finally, chi-square analyses were also conducted to compare the three weight loss 
groups on other substance use. Given that many of the substance use variables were highly 
skewed and kurtotic, the PI dichotomized them into “Never Engaged” for participants who 
never engaged in the behavior in the past year, and “Yes Engaged” for participants reporting 
having engaged in the behavior on at least 1-2 occasions in the past year (i.e., 1-2 occasions 
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to 40 or more occasions). The NMUPS/weight loss group had significantly greater reporting 
of all of the assessed substances compared to the other two groups. See Table 19. 
Table 19.  
Three weight loss groups and other substance use—past year.   
Substance Individuals 
reporting 
NMUPS/other 
weight loss 
methods (n = 
89) % 
reporting:  
Individuals 
reporting 
weight loss 
methods/no 
NMUPS (n = 
1340) % 
reporting:  
Individuals 
reporting no 
weight loss 
methods (n = 
97) % 
reporting:  
 
χ2 
Alcohol (beer, wine, 
liquor)   
95.5a 83.2b 77.3b 11.92** 
Marijuana (pot, weed, 
hashish, hash oil) 
89.8a 40.2b 46.4b 82.82*** 
Tobacco products 
(Cigarettes, water 
pipe, cigars, 
smokeless tobacco)   
83.1a 42.6b 46.4b 55.395*** 
Energy Drinks 78.4a 57.2b 50.5b 17.63*** 
MDMA (Ecstasy)   48.9a 7.7b 11.6b 149.96*** 
Cocaine (crack, rock, 
freebase, powder) 
44.9a 7.6b 11.3b 128.77*** 
Other amphetamines 
(bennies) 
39.3a 6.3b 6.2b 120.73*** 
Opiates (heroin, 
smack) 
30.3a 4.6b 7.3b 94.56*** 
Methamphetamine 
(crystal meth, ice, 
crank) 
28.1a 3.0b 4.2b 120.68*** 
Anabolic steroids 
(Testosterone)   
13.6a 2.9b 2.1b 28.52*** 
 
Note. n ranges from 1501-1523. ns = not significant. Different subscript letters represent 
values that are significantly different. ** p < .01, *** p < .001. 
 
Discussion 
The current study investigated NMUPS for weight loss in a national, young adult 
sample, and assessed its relation with other problematic cognitions and health behaviors, 
	  62 
including disordered eating. In addition, motivations and attitudes about NMUPS were 
evaluated, as these constructs might be most amenable to change in a future intervention. 
Aim 1  
The first aim of this study was to examine the prevalence of NMUPS for weight loss 
in a broad, national sample of young adults. Young adults, ages 18-25, were recruited 
because they are the group most likely to engage in NMUPS (SAMHSA, 2012) and are also 
at high risk for disordered eating behaviors (Neumark-Sztainer et al., 2011). Overall, 
recruiting participants from MTurk was a relatively easy and inexpensive method, which 
yielded good quality results. Given that participants were required to be within a certain age 
range, reside in the U.S., and speak English, the turnaround was fairly quick at approximately 
6 months for recruitment. (Additionally, recruitment time would have been quicker had there 
not been errors with initial implementation.) Moreover, participants’ state residencies were 
highly representative of the U.S. population, and participants were ethnically diverse, 
although not quite as diverse as the national population. For example, the current sample had 
lower rates of African-American and Hispanic/Latino participants compared with the 
national population (U.S. Census Bureau, 2014b). Additionally, the current sample had more 
females (62.6% versus 50.8%; U.S. Census Bureau, 2014b).  
Approximately 12.0% of the total sample reported ever engaging in NMUPS for 
weight loss, which is comparable to the rate found in a previous study among college 
students (i.e., 11.7%; Jeffers et al., 2013). However, a limitation of that study included not 
clearly differentiating between those who misused their own ADHD medication from those 
who received medication from another source. The current study solely examined those who 
engaged in non-medical use, given that prescription stimulant use may be especially harmful 
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for those who do not have a prescription from a physician (Benson et al., 2015), which is 
similar to the sample examined in the Jeffers & Benotsch (2014) investigation. However, the 
current study’s rate of NMUPS (12.1%) is much higher than results from that study (4.4%). 
Moreover, the prevalence rate for past year NMUPS for weight loss of 5.8% is higher than 
the previous investigation’s lifetime rate. According to results from the current study, this 
behavior had statistically significant higher rates in the Northeast region. Thus, the current 
study’s prevalence rate might be higher than the rate in prior studies (i.e., Jeffers & Benotsch, 
2014; Jeffers et al., 2013) given that all U.S. regions were examined (i.e., not solely Virginia 
as with the previous studies), particularly the Northeast region. Higher rates of NMUPS for 
weight loss in the Northeast is similar to past research that has demonstrated higher rates in 
this U.S. region for rates of NMUPS, in general (Johnston, O’Malley, & Bachman, 2003; 
McCabe, Knight, Teter, & Wechsler, 2005). One suggested reason for these high prevalence 
rates, at least related to college students, is that many of the institutions in the Northeast have 
more competitive admissions standards; thus, individuals might feel the need to use 
stimulants to enhance academic performance (McCabe et al., 2005). It could also be that this 
study’s prevalence rate is higher given that both college and non-college populations were 
examined. Additionally, prior research has demonstrated that the most commonly endorsed 
motives for NMUPS among college students are related to academics (Flory et al., 2014; 
Herman-Stahl et al., 2007; Teter et al., 2006), but it could be that individuals are 
underreporting stimulant use for weight loss due to a perceived stigma surrounding misusing 
one’s medication or engaging in non-medical use for a less “acceptable” purpose.  
For example, Lookatch, Moore, and Katz (2014) studied the impact of both gender 
and motivations on college students’ perceptions of NMUPS using vignettes, which included 
	  64 
either a college man or woman engaging in NMUPS for one of three motives: to get high, 
study, or lose weight. They found that, regardless of gender, using a prescription stimulant as 
a study aid was viewed more favorably than for the purposes of getting high or losing weight. 
The authors posited that greater acceptability of using a stimulant to study might be 
attributable to the similarity to the medication’s intended uses, such that individuals with 
ADHD are often prescribed the medication to improve concentration and attention. Thus, an 
individual without ADHD using the medication for the same purposes is seen as acceptable. 
Consequently, college students may be more willing to share their experiences with NMUPS 
regarding “acceptable” study motives, compared with using the medication as a weight loss 
aid. 
The top five reported motivations for both lifetime and past year NMUPS were: to 
increase concentration, to increase energy, as a study aid, to increase alertness, and to get 
high. Unsurprisingly, the majority of these motives are related to enhancing academic (or 
other work-related) performance and are consistent with findings from previous research 
(Teter et al., 2006). However, although weight loss/appetite suppression is not one of the 
most commonly reported motives, a substantial percentage of individuals reported engaging 
in this behavior over their lifetime (12.1%), over one-third of participants reporting NMUPS 
reported doing so for this purpose, and of those reporting NMUPS for weight loss, 
approximately half reported past year use.  
Aim 2  
The second aim of this study was to investigate correlates of NMUPS for weight loss, 
including negative consequences associated with this misuse, age of onset, factors 
influencing participants’ decision to use prescription stimulants for weight loss, knowledge 
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about these medications, medication source, and perceived effectiveness of NMUPS for 
weight loss. Female and transgender participants were more likely than males to report 
engaging in NMUPS for weight loss. This finding is different from prior research in which 
rates were comparable among both men and women (Jeffers & Benotsch, 2014; Jeffers et al., 
2013). The current study provides evidence that, in the general young adult population, 
women may be more likely to engage in this behavior, whereas, in college-only populations, 
like women, men are increasingly concerned about body image and weight (Pope, Gruber, 
Choi, Olivardia, & Phillips, 1997) and are not immune to engaging in unhealthy weight loss 
behaviors (Petrie, Greenleaf, Reel, & Carter, 2008). Indeed, the college environment has 
been implicated in the development of body dissatisfaction and disordered eating in both 
women (Fitzsimmons-Craft, 2011) and men (Davila et al., 2014), and individuals may be 
especially prone to seek out novel ways to lose weight. Additionally, the current study is the 
first to examine such use among transgender individuals; however, it is important to note that 
the sample size of transgender participants was relatively small (i.e., n = 33). White and non-
White participants reported similar rates of the behavior. Results regarding race have been 
inconsistent in prior research; rates among both Whites and non-Whites have been 
comparable (Jeffers & Benotsch, 2014), and results have also demonstrated Whites are more 
likely to engage in the behavior compared with non-White participants (Jeffers et al., 2013). 
Thus, current results provide evidence that the racial/ethnic gap regarding weight concerns 
and related behaviors is closing (Neumark-Sztainer et al., 2002). Indeed, research has shown 
that among adolescents, weight-related concerns (e.g., body dissatisfaction) and behaviors 
(e.g., vomiting) are prevalent irrespective of racial/ethnic background (Neumark-Sztainer et 
al., 2002). Further, slightly older participants were more likely to report NMUPS for weight 
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loss, compared to previous studies where age did not differ with only college student samples 
(Jeffers & Benotsch, 2014; Jeffers et al., 2013). It is likely that these previous studies did not 
have the power to distinguish between slight differences in age given the smaller sample 
sizes. Participants reporting NMUPS for weight loss were also more likely to have a slightly 
higher BMI than those who did not. Prior research has found NMUPS for weight loss to be 
associated with both having a lower BMI (Jeffers & Benotsch, 2014), as well as no 
differences between those reporting NMUPS for weight loss and those not reporting the 
behavior (Jeffers et al., 2013). Results of the current study make sense in that NMUPS for 
weight loss might be more appealing to individuals who are overweight. Thus, they may be 
more willing to engage in a risky behavior to lose weight. However, it could be that in 
previous research where NMUPS for weight loss was associated with a lower BMI, 
individuals indeed had a lower BMI as a result of engaging in this behavior. It is also 
important to note that the current sample was slightly overweight in general. Further research 
should better identify which individuals are most likely to engage in this behavior, and 
individuals’ perceptions of their BMI’s before and after using a stimulant for weight loss. 
Additionally, participants with a high school diploma/GED or less than a high school 
education were more likely to report use for weight loss compared to participants who had 
completed at least one year of college/university or higher. This seems counterintuitive given 
that many studies report higher rates of NMUPS among college students than their non-
college peers (Herman-Stahl et al., 2007). However, these studies typically focus on motives 
related to improving school performance. It makes sense that individuals attending or who 
have previously attended college would be more likely to use ADHD medications for such 
motivations; whereas, losing weight is important for all types of people in the general 
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population. This finding provides evidence that non-college young adults are clearly at risk 
of engaging in NMUPS for weight loss.  
Participants also reported a number of negative consequences associated with 
NMUPS. While all participants who had ever engaged in NMUPS were asked about negative 
consequences, only those who had ever engaged in NMUPS for weight loss were selected in 
analyses. Thus, it is important to note that it cannot be discerned whether consequences 
experienced were a result of NMUPS for weight loss, or NMUPS, in general. The top 
reported consequence experienced in one’s lifetime, but not in the past year, was losing 
weight or not eating properly. Approximately one-third of participants also reported that they 
enjoyed using stimulants, had taken stimulants in larger amounts or over a longer period of 
time than planned, felt bad physically due to stimulant use, and had done impulsive things 
they later regretted. Approximately 8.0% of participants reported that they needed medical 
treatment and 11.0% reported that they had to go to the ER as a consequence of NMUPS.  
According to a news release from Johns Hopkins Bloomberg School of Public Health 
(Johns Hopkins Bloomberg School of Public Health, 2016), a recent study found that the 
number of prescriptions for Adderall has remained unchanged, but rates of non-medical use 
and ER visits related to the drug have increased dramatically among young adults (Chen et 
al., 2016). Such medical consequences undoubtedly have productivity and financial 
implications. For example, individuals undergoing treatment are pulled away from work and 
other obligations. Additionally, although there are no economic data on the abuse of 
prescription stimulants, prescription opioid abuse alone costs health insurers up to $72.5 
billion a year (Coalition Against Insurance Fraud, 2007). One could expect a similarly 
significant financial burden given a rise in non-medical use and ER visits related to 
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prescription stimulants. Estimating this financial impact is an important gap for future 
research to explore.  
Past year consequences associated with NMUPS for weight loss were similar. The top 
five commonly-reported consequences were the same with the exception that approximately 
40.0% of participants felt guilty or ashamed due to their stimulant use, and taking stimulants 
in larger amounts or over a longer period of time than planned was moved to eighth on the 
list. To the PI’s knowledge, this is the first study to examine an extensive list of 
consequences associated with NMUPS, particularly NMUPS for weight loss. Prior research 
has demonstrated associations with NMUPS and negative consequences, including major 
depressive episodes (Ali et al., 2015), but causality cannot be determined. Future research 
should incorporate longitudinal studies to provide better indications of temporal precedence, 
and examinations of a broad range of consequences similar to that of the current study, in 
addition to examining consequences solely as a result of NMUPS for weight loss.  
Participants reported that they started engaging in NMUPS for weight loss ranging 
from 12 to 24 years, with a mean age of 18 years. Around 8.5% of participants reported 
starting during middle school, over one-third reported starting during high school years, and 
the majority reported starting at age 18 and over. It is not surprising that a substantial 
minority of participants reported that they started engaging in NMUPS for weight loss during 
adolescence, as adolescents are the second largest age group (following young adults) to 
engage in NMUPD (SAMHSA, 2014). Moreover, NMUPS can begin as early as grade 
school (Wilens et al., 2008). A systematic review examining the misuse and diversion of 
medications prescribed for ADHD found that children with medications receive requests to 
give, sell, or trade them to other students in elementary and high school (Wilens et al., 2008). 
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Further, adolescents with stimulant prescriptions for ADHD are more likely to be approached 
to divert their medications compared to individuals with prescriptions for pain, anti-anxiety, 
and sleeping medications (McCabe et al., 2011). 
Almost 75.0% of the participants reported that they decided to try a prescription 
stimulant without a doctor’s orders specifically for the purpose of weight loss/appetite 
suppressive effects due to knowing someone else who was doing it or someone else giving 
his/her ADHD medication specifically for that purpose. This is not surprising given the high 
rates with which ADHD medications are diverted (McCabe et al., 2011), especially from 
friends and family (Jeffers et al., 2014; NIDA, 2013). Indeed, friends and family were the top 
two sources of stimulant medications. Almost 20.0% heard about the idea from the media, 
and the rest of the participants decided to try this behavior for other reasons not listed. 
Participants also reported receiving medication from the Internet, a stranger, and other 
sources. Stealing medication was reported by at least one participant who reported getting the 
medication from a “teenager whose house I was watching while they were away.”  
A majority of participants reported that engaging in NMUPS for weight loss was 
either “mildly” or “very effective” (43.1%, 21.3%, respectively). Perceived effectiveness was 
somewhat better in this study compared to prior work (Jeffers et al., 2014). Indeed, a smaller 
percentage of participants reported that NMUPS for weight loss was “not at all effective.” 
Future work should examine individuals’ perceptions regarding the pros and cons when 
utilizing this weight loss technique. 
The greatest source of exposure to information about side effects associated with the 
use of ADHD medication was the Internet. This is in line with prior research demonstrating 
that some of the most frequently sought topics on the Internet are related to health and 
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medical information (McMullan, 2006). It is likely that the other students/friends who acted 
as the next greatest sources of information were also the medication suppliers. Finally, 
approximately one-third of participants reported receiving exposure to information about 
ADHD medication in school.  
The majority of participants reported that they considered themselves to be 
knowledgeable about the side effects associated with the use of stimulant medication 
normally used to treat ADHD. However, there was only a moderate correlation between 
participants’ confidence in their knowledge about side effects and their actual knowledge. 
The total mean score of side effects and contraindications that were answered correctly were 
60.0% and 43.0%, respectively. These percentages are concerning given that individuals are 
taking a medication that could negatively impact their health, especially without medical 
supervision. Further, it is not clear whether individuals had this knowledge prior to engaging 
in NMUPS, or whether their knowledge was a consequence of having experienced a 
particular side effect (e.g., correctly identified tachycardia as a possible side effect because of 
experiencing a racing heart while taking the medication). Judson and Langdon (2009) also 
found that college students who engaged in illicit use without a prescription had higher 
knowledge scores compared with non-users, and suggested that such knowledge primarily 
results from experience.  
Aim 3 
The third aim of this study was to evaluate the utility of the TPB model to predict 
membership in one of two groups: individuals who had engaged in NMUPS for weight loss 
in the past year and individuals who had tried to lose weight via other methods in the past 
year. Using items modeled after a sample TPB questionnaire (Ajzen, n.d.-a) and Judson and 
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Langdon (2009), the TPB did provide adequate overall fit to the data. Although the chi-
square test was statistically significant, thus indicating a poor fitting model, this fit index is 
impacted by sample size and is typically significant for models with greater than 200 cases 
(Kenny, 2015). Therefore, it is important to examine more than one fit index. Currently, the 
most popular measure of model fit is the RMSEA (Kenny, 2015), which indicated an 
adequately fitting model for the current results. Indeed, half of the subjective norms factors 
and both perceived behavioral control factors were significantly associated with NMUPS for 
weight loss, indicating that those with greater subjective norms regarding knowing at least 
one person who uses stimulant medication for the purpose of weight loss/appetite 
suppression, in addition to believing that NMUPS is common were more likely to report 
NMUPS for weight loss. Further, participants reporting NMUPS for weight loss had lower 
perceived behavioral control, indicating that they were more likely to agree that they do need 
stimulant medication to help them lose weight/control their appetite, and that they could not 
lose weight successfully without the help of a stimulant medication. Those reporting NMUPS 
for weight loss also had higher perceived behavioral control regarding feeling confident that 
they could obtain a stimulant medication from someone if they wanted to. Thus, the 
hypothesis that “individuals who have engaged in NMUPS for weight loss will have more 
favorable attitudes toward the behavior (e.g., view the behavior as ethical), view the behavior 
as common, and have lower perceived behavioral control to lose weight without the help of 
stimulants, as well as higher perceived behavioral control to obtain stimulant medication 
compared to the other group” was partially supported. 
It is interesting that attitudes was not associated with NMUPS for weight loss in the 
TPB model, especially given that there were significant correlations among the three 
	  72 
attitudes factors, and that many of the separate factors of the latent constructs were correlated 
in their expected directions. For example, those who were more likely to feel that engaging in 
NMUPS is ethical and safe were less likely to be concerned that NMUPS would adversely 
affect a person’s health, in addition to feeling the benefits of NMUPS outweigh the potential 
risks. Further, those who were less likely to be concerned that NMUPS would adversely 
affect a person’s health were more likely to feel the benefits of NMUPS outweigh the 
potential risks.  
There were also significant correlations among some of the attitude and subjective 
norms factors, such that those who were more likely to feel that engaging in NMUPS is 
ethical and safe were also more likely to perceive greater social acceptability toward NMUPS, 
in addition to knowing at least one person who engages in NMUPS for the purpose of weight 
loss/appetite suppression. Those who were less likely to be concerned that NMUPS would 
adversely affect a person’s health were more likely to perceive greater social acceptability 
toward NMUPS, in addition to knowing at least one person who engages in NMUPS for the 
purpose of weight loss/appetite suppression. Further, those who were more likely to be 
concerned that NMUPS would adversely affect a person’s health were more likely to value 
their friends’/ family’s / significant other’s opinion on whether or not it is okay for people to 
engage in NMUPS, in addition to believing NMUPS is common. Those who were more 
likely to feel the benefits of NMUPS outweigh the potential risks were also more likely to 
perceive greater social acceptability toward NMUPS, in addition to knowing at least one 
person who engages in NMUPS for the purpose of weight loss/appetite suppression. 
Finally, there were many significant correlations among the attitudes and perceived 
behavioral control factors. Those who were more likely to feel that engaging in NMUPS is 
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ethical and safe were less likely to feel that they could lose weight without the help of a 
stimulant medication, in addition to feeling that they could obtain a stimulant medication if 
they wanted to. Those who were more likely to be concerned that NMUPS would adversely 
affect a person’s health were more likely to feel that they could lose weight successfully 
without the help of a stimulant medication. Further, those who were more likely to feel the 
benefits of NMUPS outweigh the potential risks were less likely to feel that they could lose 
weight successfully without the help of a stimulant medication, and were more confident in 
feeling that they could obtain a stimulant medication if they wanted to. 
The current study’s findings are slightly different from Judson and Langdon’s (2009) 
results. They found that, among college students who engaged in NMUPS, results were 
consistent with the TPB, such that they had fewer concerns regarding adverse health effects 
and ethics of use, higher perceived positive social norms, and lower perceived behavioral 
control (i.e., felt more dependent on stimulant medications). For those who misused their 
own prescriptions, only social norms approached significance for predicting use. 
In Gallucci’s (2011) dissertation study of undergraduates, attitudes and perceived 
behavioral control were related to lifetime NMUPS; social norms, however, were not related. 
His study also differs from the current study’s results, but it is important to note that the 
social norm variables in the former study were associated with higher numbers of 
participants who had incomplete data, and that this may have been a result of survey 
administration (e.g., close proximity to friends in the classroom during survey completion), 
whereas the current study provided participants complete privacy in an online environment. 
Only perceived behavioral control was related to recent non-medical use (i.e., past 30 days), 
which is one of the main findings Gallucci published from his dissertation (Gallucci et al., 
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2015). The authors note that non-significant relations between current NMUPS and attitudes 
and subjective norms differs from Judson and Langdon’s (2009) results, but that the 
inconsistencies could be attributable to differing time frames used in the studies. Gallucci et 
al. examined past 30 day use, whereas Judson and Langdon examined lifetime NMUPS. 
However, lower perceived behavioral control was related to NMUPS in both studies. Another 
important distinction between Gallucci et al.’s study and the current study is that the former 
examined individuals who engaged in both NMUPS and misuse, whereas this study 
examined NMUPS only. Additionally, Judson and Langdon examined illicit use separately 
among prescription and non-prescription holders and found differing results. 
In Srigley’s (2013) master’s thesis, both attitude toward use and perceived behavioral 
control emerged as strong predictors of intention to engage in NMUPD within the next year 
in a sample of 131 college students. Srigley’s findings also differ from the current study’s 
results, but inconsistencies might be attributable to such large differences in sample size, 
college student sample versus national young adult sample, or that Srigley examined 
intention to use, whereas the current study predicted past year use. However, it is important 
to note that, as with Gallucci et al.’s (2015) study and Judson and Langdon’s (2009) study, 
the current study did not measure intention to use because Ajzen (1991, 2002) claimed that 
addictive behaviors have the potential to bypass intention. Thus, it can be assumed that any 
participant who reported engaging in past year NMUPS for weight loss intended on doing so 
(Gallucci et al., 2015). 
Lastly, Ponnet and colleagues (Ponnet et al., 2015) used an extended model of the 
TPB to examine Flemish college students’ intention to engage in NMUPS to enhance 
academic performance. They found that subjective norms, followed by attitudes and 
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perceived behavioral control predicted intention to use, among other variables (e.g., 
substance abuse). 
There are a variety of factors that might contribute to the inconsistent findings among 
the current study and the previous studies utilizing the TPB to predict NMUPS. Differing 
time frames (e.g., lifetime, recent, past year use), differentiating between NMUPS and 
misuse, large versus small sample sizes, college student samples versus national sample, 
motives for use (i.e., in general, for academic purposes only, and for weight loss), and how 
the constructs (i.e., attitudes, norms, perceived behavioral control) were conceptualized 
might attribute to inconsistent results. Thus, it is difficult to discern whether the TPB appears 
to have limited utility in predicting NMUPS due to such methodological differences, or 
whether the TPB is in fact not the best model for predicting this behavior. Overall, however, 
in the majority of these studies, at least some elements of the TPB significantly predict 
NMUPS, the most consistent being perceived behavioral control. Findings indicate that this 
TPB element might be most useful in predicting NMUPS, whether in general or for weight 
loss purposes.   
Aim 4  
The fourth aim of this study was to compare the three groups on additional relevant 
behaviors and constructs: disordered eating behaviors, body image, other substance use, and 
depressive symptomatology. The NMUPS/weight loss group had greater body dissatisfaction 
than both the weight loss/no NMUPS group and no weight loss group. Further, results for 
body dissatisfaction were observed in expected directions among the three groups, such that 
the weight loss/no NMUPS group had even greater body dissatisfaction than the no weight 
loss group. Similarly, the NMUPS/weight loss group felt greater pressure from the media to 
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have an ideal body image than both the weight loss/no NMUPS group and no weight loss 
group; the same linear pattern was observed. These findings are consistent with past research 
(Jeffers & Benotsch, 2014). However, the current study provides evidence that those 
engaging in NMUPS for weight loss are even more dissatisfied with their bodies and feel 
even greater pressure from the media to have an ideal body type compared with individuals 
who engage in weight loss methods other than NMUPS.  
The NMUPS/weight loss group had poorer eating attitudes and more eating disorder 
symptomatology than the weight loss/no NMUPS group, and again, this weight loss group 
had poorer eating attitudes and symptomatology than the no weight loss group. Both regular 
binge eating episodes and dietary restraint were most commonly reported by individuals in 
the NMUPS/weight loss group, followed by individuals in the weight loss/no NMUPS group, 
followed by individuals in the no weight loss group. Regular episodes of vomiting, laxative 
use, and excessive exercise were all more frequently reported in the NMUPS/weight loss 
group; however, rates were similar for the weight loss/no NMUPS group and no weight loss 
group. Further, the NMUPS/weight loss group had greater reporting of all of the additional 
unhealthy weight loss behaviors that were assessed compared to the weight loss/no NMUPS 
group: fasting, eating very little food, using diet pills, using diuretics, using food 
substitutions, skipping meals, smoking more cigarettes for appetite control, following a high 
protein/low carbohydrate diet (i.e., fad diet), and drinking energy drinks for appetite control. 
Overall, findings are consistent with past research (Jeffers & Benotsch, 2014; Jeffers et al., 
2013). However, the current study provides evidence that those engaging in NMUPS for 
weight loss have even poorer eating attitudes, are engaging in even more binge eating 
episodes, and dietary restraint compared with individuals who engage in weight loss methods 
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other than NMUPS. It could be that rates for regular episodes of vomiting, laxative use, and 
excessive exercise were similar for the weight loss/no NMUPS group and no weight loss 
groups because such low rates were reported in general among the two groups. Regardless, 
individuals who engage in NMUPS for weight loss tend to endorse more unhealthy attitudes 
and behaviors compared with those who utilize other weight loss techniques. 
All healthy weight loss behaviors that were assessed had similar frequency rates 
among the two groups, with the exception of the NMUPS/weight loss group reporting higher 
frequency of watching portion sizes. This finding might make sense in that watching portion 
sizes may easily lend itself into becoming an unhealthy behavior, such as eating very little 
food. Given these data, it appears that individuals who engage in NMUPS for weight loss are 
not simply just engaging in any and every weight loss technique (i.e., both healthy and 
unhealthy strategies), but are much more likely to engage in problematic and unhealthy 
weight loss strategies. 
Additionally, the NMUPS/weight loss group also exhibited greater depressive 
symptomatology than both the weight loss/no NMUPS group and no weight loss group. 
However, the weight loss/no NMUPS group and no weight loss group reported comparable 
rates of depressive symptomatology. The current findings are consistent with past research; 
NMUPD has been associated with poor mental health, including depressive symptoms, 
suicidality, and anxiety among college students (Dussault & Weyandt, 2013; Zullig & Divin, 
2012). Ali et al. (2015) also found a positive relation between NMUPD and major depressive 
episodes among adolescents.  
Finally, the NMUPS/weight loss group had significantly greater reporting of all of the 
assessed substances compared to the other two groups, which reported comparable substance 
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use rates. Indeed, the NMUPS/weight loss group reported surprisingly high rates for many of 
the substances, including: marijuana (89.8%, almost double that of the other two groups), 
cocaine (44.9%, approximately four-times that of the other groups), and ecstasy (48.9%, 
approximately four-times that of the other groups). This is similar to prior research in which 
college students who reported NMUPS for weight loss were more likely to report using illicit 
drugs but not alcohol over the past 3 months compared to non-users (Jeffers & Benotsch, 
2014); although, in the current study, users were more likely to report alcohol use compared 
with non-users. Additionally, NMUPS has been associated with other substance use 
including use of alcohol, tobacco, marijuana, cocaine, and ecstasy (Lanier & Farley, 2011). 
NMUPS is also associated with past year alcohol or drug use disorders in both males and 
females (Wu et al., 2007). 
Data from this national sample demonstrates that individuals who are engaging in 
stimulant use for weight loss are also highly more likely to use many other substances. Future 
research should examine whether ADHD medication facilitates more as a gateway drug, or if 
other substance use precipitates using ADHD medication non-medically. In one longitudinal 
study of college students, energy drink users consumed more alcohol and were more likely to 
have used other drugs, both in the same year and in the preceding year (Arria et al., 2010). 
Results demonstrated that Year 2 energy drink use was significantly associated with Year 3 
NMUPS and non-medical use of prescription analgesics, but was not associated with other 
drug use in Year 3. Additionally, Woolsey et al. (2015) found that energy drink use 
frequency was a significant predictor of NMUPS. Using data from the same longitudinal 
study mentioned above, Arria et al. (2013) found that as cannabis and alcohol use increased, 
college students experienced associated increases in skipping class and decreases in GPA, 
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which in turn led to a higher likelihood of engaging in NMUPS for study purposes. Data 
from national samples have demonstrated that NMUPD is a risk factor for future drug 
dependence (Schepis & Krishnan-Sarin, 2008), binge drinking (McCauley et al., 2011), and 
substance use disorders (Schepis & Hakes, 2011). Additional longitudinal work is needed to 
disentangle which substance comes first, and whether this is dependent upon motive (e.g., 
energy drink use leads to NMUPS for study aid purposes, NMUPS leads to cocaine use for 
getting high purposes). Moreover, future work should determine if individuals engaging in 
NMUPS for weight loss are using some of these drugs simultaneously.  
The hypothesis that “the three groups will differ on various constructs, such that 
individuals who engage in NMUPS for weight loss will have poorer body image, higher rates 
of disordered eating, higher rates of other substance use, and greater depressive 
symptomatology compared to the other two groups” was fully supported.  
Limitations and Strengths 
 Limitations of this study should be considered when interpreting findings. All 
measures were based on self-report, which may have resulted in biases or errors in reporting. 
For example, BMI was calculated based on self-reported weight and height; thus, data 
analyses regarding BMI might have been slightly inaccurate. However, prior research has 
demonstrated that web-based self-reports of height and weight are moderately to highly 
correlated with actual height and weight, and suggest that online self-reported measurements 
can be a valid method of data collection (Bonn, Lagerros, & Bälter, 2013; Pursey, Burrows, 
Stanwell, & Collins, 2014). Similarly, the online nature of the study did not allow for a 
controlled testing environment, such as preventing or controlling for outside distractions. 
Further, there may have been a response bias as participants self-selected to participate in a 
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study titled “Substance use, eating behaviors, mental health, and weight loss.” Such self-
selection might impact the generalizability of results to the overall population. Further, an 
Internet sample might not be representative of the general population. For example, MTurk 
workers tend to be more educated than the general U.S. population, which may reflect higher 
education levels among technology users (Paolacci et al., 2010). MTurk samples also have a 
large proportion of both White and female participants, which is comparable to 
characteristics of other Internet samples (Casler et al., 2013; Shapiro et al., 2013). Indeed, the 
current sample also had a larger proportion of females compared with the national 
population; however, this is not atypical of many psychological studies. Additionally, the 
observational design limits interpretations of causality.  
 Despite limitations, this study had numerous strengths. To the PI’s knowledge, this is 
the first study to examine NMUPS for weight loss in a national sample of young adults, as 
well as the first to examine this behavior in both participants attending college and those not 
attending college. Further, there was a large correlation between participants’ state 
residencies and the U.S. population, and participants were fairly ethnically diverse. This is 
also the first study to apply a theoretical model when examining NMUPS for weight loss. 
Further, using SEM allowed for the estimation of latent variables, thus eliminating random 
error (Hays et al., 2005). The current study also provides additional evidence regarding prior 
inconsistent results for “building a profile” of the typical NMUPS for weight loss user, 
including supporting higher rates among females and similar rates among White and non-
White participants. This is also the first study to examine such use among transgender 
individuals (who, along with female participants, were more likely to report this behavior 
compared with males). However, it is important to note that this sample included a small 
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percentage of transgender participants and findings are preliminary. To the PI’s knowledge, 
this is the first study to examine an extensive list of consequences associated with NMUPS. 
This is also one of the first studies to indicate that many individuals begin NMUPS for 
weight loss during adolescence. 
Implications and Future Directions  
This study provides evidence that a large percentage of young adults are engaging in 
NMUPS (approximately one-third), and a substantial minority of individuals are engaging in 
NMUPS for weight loss (approximately 12.0%). Many of these young adults also report a 
variety of negative consequences associated with this use. Future research should utilize 
longitudinal designs and examine how subsequent use is related to such consequences (e.g., 
continuing use despite a trip to the ER as a result of NMUPS), in addition to examining 
consequences resulting solely as a function of NMUPS for weight loss. Additionally, future 
research should examine individuals’ perceptions regarding the pros and cons when utilizing 
this weight loss technique, and why they feel the “need” to use stimulants to lose weight. 
Further, additional work should examine this behavior among transgender individuals given 
the high rate found in this study. 
Investigation into NMUPS for weight loss in adolescents is also needed, as current 
results suggest this behavior often begins during this developmental stage. Further, prior 
research provides evidence that NMUPD frequently begins during adolescence (Wilens et al., 
2008; Young, Glover, & Havens, 2012). The relation between NMUPD and other substance 
use also begins in adolescence (Nakawaki & Crano, 2012; Young et al., 2012). Moreover, 
adolescence is a common time for the onset of many eating disorder symptoms and unhealthy 
weight control behaviors (Hoste, Labuschagne, & Le Grange, 2012; Neumark-Sztainer et al., 
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2011; Rawana, Morgan, Nguyen, & Craig, 2010; Vander Wal, 2012). Only one study has 
examined motivations for NMUPD in a nationally representative sample of high school 
seniors, and prescription stimulants were the largest class of non-medically used drugs 
(McCabe & Cranford, 2012). Notably, 35.5% of individuals who reported NMUPS indicated 
doing so to help with weight loss.  
The current study clearly provides evidence that non-college young adults are at risk 
of engaging in NMUPS, and for weight loss in particular. Given the finding that participants 
with a high school diploma/GED or less than a high school education were more likely to 
report use compared to participants who had completed at least one year of college/university 
or higher, future investigations should better elucidate NMUPS for weight loss rates, and 
other motives (e.g., academic) among different educational groups. For example, future work 
might compare/contrast non-college individuals, individuals currently attending college, and 
those who have graduated college. Further, as with Lookatch et al.’s study (2014), it could be 
useful to examine how stigma surrounding certain motives might also play a role. 
Despite the finding that attitudes were not significant in the final SEM, the TPB did 
provide an adequate overall fit to the data. Two of the four subjective norms factors and both 
perceived behavioral control factors were significantly associated with NMUPS for weight 
loss, and many of the separate factors of the latent constructs were significantly correlated 
with each other in expected directions; thus, the TPB could provide useful information when 
examining NMUPS for weight loss in future samples. Additionally, current results and prior 
studies provide evidence that perceived behavioral control significantly predicts NMUPS, 
and might be most useful in predicting NMUPS, whether in general or for weight loss 
purposes.  
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Future investigations should also examine misuse of prescription stimulants for 
weight loss in a national sample, the utility of the TPB to predict this behavior, in addition to 
other correlates examined in the current study. It would be interesting to see whether findings 
differ depending on whether one engages in non-medical use, misuses one’s own prescription, 
or if engaging in both of these behaviors yields different results. Future longitudinal research 
should examine whether ADHD medication facilitates as a gateway drug, or if other 
substance use precipitates misusing one’s ADHD medication, or using non-medically.   
Additionally, future qualitative work may aid in the exploration of this research and 
gain a complex, detailed understanding of the issue. In particular, it is important to capture 
the “essence” of the behavior by understanding experiences of NMUPS for weight loss and 
the context and situations that influence the behavior. Additionally, answers that are not 
easily captured in quantitative surveys (or are limited in their response), such as the 
advantages/disadvantages to losing weight this way, situations that promote this behavior, 
and perhaps instances of polysubstance use would benefit from qualitative inquiry. Moreover, 
qualitative methodology has typically been neglected in past NMUPD research (DeSantis et 
al., 2008), and especially with regard to NMUPS for weight loss.  
Eating disorder prevention and intervention programs would benefit from assessing 
NMUPS for weight loss and educating young adults about associated dangers. Clinicians 
should also include this behavior when assessing unhealthy weight loss practices given that 
many of the individuals who have engaged in NMUPS for weight loss have also engaged in 
better known problematic ways to lose weight. Approximately 67.0%, 35.0%, 21.0%, and 
14.0% of participants reporting this behavior also took diet pills, used diuretics, vomited to 
lose weight, and used laxatives, respectively. When prescribing ADHD medications, 
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physicians should emphasize the harmful consequences associated with sharing prescriptions 
and taking medications for purposes other than intended. Quality education concerning side 
effects and contraindications is especially important given such disconcertingly low rates 
regarding medication knowledge. NMUPD awareness campaigns should include information 
regarding NMUPS for weight loss and negative health consequences. 
Programs and interventions focused on preventing or reducing NMUPS for weight 
loss could address beliefs about use and other motives. Because there are a variety of motives 
associated with NMUPS and many individuals endorse more than one motive, interventions 
might benefit from shining light on these other motives. Messages framed to suggest that 
despite the perception that non-medical use might seem socially acceptable, but is indeed 
illegal, unethical, and unsafe might be beneficial. An additional component might include 
providing anecdotal and/or statistical evidence of negative consequences including ER visits 
(e.g., 10.9%), feeling bad physically (e.g., 27.1%), and doing impulsive things that are 
subsequently regretted (e.g., 26.9%). Moreover, given that non-medical users were more 
likely to perceive that they “needed” stimulant medication to aid in successful weight loss, 
methods aimed at increasing perceived behavioral control regarding stimulant use and weight 
loss could be a particularly essential component in an intervention. Further, methods aimed at 
changing perceptions surrounding subjective norms regarding the belief that NMUPS is 
common would be useful. 
Emphasizing healthful and sustaining weight loss strategies, while simultaneously 
underscoring negative consequences associated with use and the harms of taking a 
prescription without supervision for unintended purposes could be beneficial. Further, given 
that almost half of individuals reporting NMUPS for weight loss in the past year reported 
	  85 
engaging in regular binge eating episodes in the past 28 days, specific techniques to deal with 
binge eating should be addressed. Techniques might include focusing on positive cognitive-
emotional coping skills, such as identifying potential stressors related to bingeing and 
brainstorming steps to deal with them (Kelly, Lydecker, & Mazzeo, 2012). Additionally, a 
key component of binge eating disorder is the sense of loss of control that accompanies a 
binge episode, which is similar to the loss of control that is associated with substance use 
disorders (Reese, Pollert, & Veilleux, 2016). This feature is one such commonality that has 
led researchers to conceptualize binge eating disorder as an addictive-spectrum disorder, like 
substance use disorders (Schreiber, Odlaug, & Grant, 2013). Thus, increasing self-control, 
and specifically addressing the perspective that self-control, or willpower, is a limited 
resource might be beneficial in reducing bingeing and substance use behavior (Reese et al., 
2016)—which seems applicable to an intervention targeting NMUPS for weight loss.  
Interventions might also benefit from incorporating components to improve mental 
health, particularly related to body image and depressive symptomatology. Body 
dissatisfaction may be especially important to highlight in relation to perceived pressures 
from the media, which have become increasingly focused on the thin-ideal for women and 
muscularity for men (Leit, Pope, & Gray, 2001; Mazur, 1986). Interventions should 
emphasize how such media images are often unrealistic (Heinberg, Thompson, & Stormer, 
1995). Increasing body appreciation may be worthwhile as this has been suggested to be an 
easier feat than attempting to decrease levels of body dissatisfaction (Andrew, Tiggemann, & 
Clark, 2014; Andrew, Tiggemann, & Clark, 2015). Strategies might include encouraging 
activities that emphasize the function, rather than the appearance, of the body, such as yoga 
and other athletics (Andrew et al., 2015; Menzel & Levine, 2011; Tylka, 2012). Interventions 
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should also include a screen for depression, in addition to coping techniques and counseling 
referrals. Further, given such high rates of additional substance use, interventions aimed at 
reducing other substance use, and educating about the harms associated with mixing 
substances and polysubstance use might result in a reduction of the behavior. Education 
surrounding seemingly harmless substances including energy drinks, as well as more well-
known harmful agents such as marijuana, cocaine, and methamphetamine should be 
incorporated.  
Conclusion 
A substantial minority of young adults are obtaining prescription stimulant 
medication for the appetite suppression and weight loss effects. Research has demonstrated 
that this non-medical use is related to disordered eating behaviors; other substance use; and 
psychological concerns, including body dissatisfaction and depressive symptomatology. 
Moreover, individuals who engage in NMUPS for weight loss tend to endorse more 
unhealthy attitudes and behaviors compared with those who utilize other weight loss 
techniques. NMUPS for weight loss is also associated with a variety of negative 
consequences and users are not well-informed regarding stimulant medication knowledge. 
While there have been mixed results concerning who engages in this behavior, prescription 
stimulants may be more appealing to women and transgender individuals (although men are 
not immune from engaging in this behavior), as well as both White and non-White 
individuals. Prospective research is needed to further examine this behavior in other 
populations (e.g., adolescents), utilizing various methodologies (e.g., qualitative inquiry), and 
longitudinal investigation. This study extends the literature on the utility of the TPB in 
examining NMUPS, and provides the first research on utilizing the TPB to examine NMUPS 
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for weight loss. Findings demonstrate that methods aimed at increasing perceived behavioral 
control regarding stimulant use and weight loss, and changing perceptions surrounding 
subjective norms could be particularly essential components in an intervention. Emphasizing 
healthful and sustaining weight loss strategies, improving mental health, educating about 
polysubstance use, and underscoring negative consequences associated with use are other 
potential intervention targets. 
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Appendix A 
Demographics 
 
 
 
1. Which best describes you?  
 Male 
 Female  
Transgender 
 
2. Which best describes you?  
       
White      
African-American      
Hispanic/Latino      
Asian-American      
Native American     
Other_________ 
 
3. How old are you? __________ 
4. How tall are you (in inches)? _________ 
5. How much do you weigh (in pounds)? __________ 
6. Which of the following best describes your highest achieved education level?  
 Less than high school 
 High school/GED 
 College or University/1st year completed 
 College or University/2nd year completed 
 College or University/3rd year completed 
 College or University/4th year completed 
 College or University/5th or higher year completed 
 2-year college degree (Associates) 
 4-year college degree (BA, BS) 
 Master’s Degree 
 Doctoral Degree 
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 Professional Degree (MD, JD) 
 
7. What was your total household income last year? 
$0-25,999  
$26,000-$51,999 
$52,000-74,999  
more than $75,000 
don’t know/decline to say 
8. Are you currently enrolled at a college or university? 
 Yes 
 No 
 
9. Have you ever been diagnosed with Attention deficit hyperactivity disorder (ADHD)? 
 
 Yes 
 No 
 
10. Have you ever been prescribed a prescription stimulant medication by a doctor to treat 
ADHD (e.g., Adderall, Ritalin, Vyvanse)? 
 
Yes   
No 
 
11. Are you currently being prescribed a prescription stimulant medication by a doctor to 
treat ADHD (e.g., Adderall, Ritalin, Vyvanse)? 
 
 Yes 
 No 
 
12a. Have you ever been prescribed a medication by a doctor for weight loss? 
 
 Yes 
 No 
 
  12b. If yes, please list the medication(s). _____________________ 
 
13. Are you currently being prescribed a medication by a doctor for weight loss? 
 
 Yes 
 No 
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14. Are you currently trying to: 
  
 a) Lose weight 
 b) Stay the same weight 
 c) Gain weight 
 d) I am not trying to do anything about my weight  
 
15. How often have you gone on a diet during the last year? By “diet” we mean changing the 
way you eat so you can lose weight. 
 a) never 
 b) 1-4 times 
 c) 5-10 times 
 d) more than 10 times 
 e) I am always dieting 
 
16. Have you ever tried to lose weight? 
 
 Yes 
No 
 
17. In which state do you live? _____________________ 
 
18. Which best describes your place of residence? 
  
 Urban 
 Rural 
 
19. Who is the president of the United States?* _____________________  
*(Quality assurance question #1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  104 
NMUPS Frequency 
 
1a. On how many occasions (if any) in your lifetime have you used a prescription stimulant 
normally used to treat ADHD (e.g., Adderall, Ritalin, Concerta, Vyvanse), NOT prescribed 
to you? 
 
1)   no occasions 
2)   1-2 occasions 
3)   3-5 occasions 
4)   6-9 occasions 
5)   10-19 occasions 
6)   20-39 occasions 
7)   40 or more occasions    
 
1b. On how many occasions (if any) in the past 12 months have you used a prescription 
stimulant normally used to treat ADHD (e.g., Adderall, Ritalin, Concerta, Vyvanse), NOT 
prescribed to you? 
 
1)   no occasions 
2)   1-2 occasions 
3)   3-5 occasions 
4)   6-9 occasions 
5)   10-19 occasions 
6)   20-39 occasions 
7)   40 or more occasions    
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Motivations for NMUPS (Lifetime) 
 
Why have you ever used 
prescription stimulants not 
prescribed to you?  
Yes No 
1. To get high 1 2 
2. Pain relief 1 2 
3. Weight loss/appetite 
suppression 
1 2 
4. Increased energy 1 2 
5. Sexual stimulant 1 2 
6. Study aid 1 2 
7. Coping with a difficult 
problem 
1 2 
8. To forget my worries 1 2 
9. To fit in and not be 
excluded 
1 2 
10. To feel more self-
confident 
1 2 
11. To reduce anxiety 1 2 
12. To increase 
concentration 
1 2 
13. To try something new 1 2 
14. Because it helps increase 
my alertness 
1 2 
15. Because it counteracts 
the effects of other drugs 
1 2 
16. Because of 
experimentation 
1 2 
17. Because it’s safer than 
street drugs 
1 2 
18. Because I’m addicted 1 2 
 
Please fill in any additional reasons you have ever used a prescription stimulant medication 
not prescribed to you. _______________ 
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Motivations for NMUPS (Past Year) 
 
In the past year, why have 
you used prescription 
stimulants not prescribed to 
you?  
Yes No 
1. To get high 1 2 
2. Pain relief 1 2 
3. Weight loss/appetite 
suppression 
1 2 
4. Increased energy 1 2 
5. Sexual stimulant 1 2 
6. Study aid 1 2 
7. Coping with a difficult 
problem 
1 2 
8. To forget my worries 1 2 
9. To fit in and not be 
excluded 
1 2 
10. To feel more self-
confident 
1 2 
11. To reduce anxiety 1 2 
12. To increase 
concentration 
1 2 
13. To try something new 1 2 
14. Because it helps increase 
my alertness 
1 2 
15. Because it counteracts 
the effects of other drugs 
1 2 
16. Because of 
experimentation 
1 2 
17. Because it’s safer than 
street drugs 
1 2 
18. Because I’m addicted 1 2 
 
Please fill in any additional reasons you have used a prescription stimulant medication not 
prescribed to you within the past year. _______________ 
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NMUPS Age of Onset 
 
1. How old were you when you started using a prescription stimulant without a doctor’s 
orders? If you can’t remember, please make your best guess. 
_______________ 
 
2. How old were you when you started using a prescription stimulant without a doctor’s 
orders specifically for the purpose of weight loss/appetite suppressive effects? If you can’t 
remember, please make your best guess. 
_______________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  108 
Decision to Engage in NMUPS for Weight Loss 
 
1. What made you decide to try a prescription stimulant without a doctor’s orders specifically 
for the purpose of weight loss/appetite suppressive effects?  
 
a)   You knew someone else who was doing it 
b)   You heard about the idea from the media (e.g., TV, radio, Internet) 
c)   Someone else gave you their ADHD medication specifically for that purpose 
d)   Other ________ 
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Medication Source for Those Who Have Engaged in NMUPS  
 
1. If you have ever used a prescription stimulant medication not prescribed to you, who did 
you get it from? 
  
 a) Friends 
 b) Family 
 c) Internet 
 d) Stranger 
 e) Other ________________ 
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Perceived Effectiveness of NMUPS for Weight Loss 
 
1. How effective has using a prescription stimulant without a doctor’s orders been in helping 
you lose weight? 
 
 1) Not at all effective 
 2) Mildly effective 
3) Somewhat effective 
4) Very effective  
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Negative Consequences Associated With NMUPS  
 
1. How often (if ever) have you experienced the following as a result of using a prescription 
stimulant without a doctor’s orders? 
 
 Never Lifetime 
but not 
past 
year 
1-2 
occasions 
in past 
year 
3-5 
occasions 
in past 
year 
6-9 
occasions 
in past 
year 
10-19 
occasions 
in past 
year 
20-39 
occasions 
in past 
year 
40+ times 
in past year 
1. Said or done 
something 
embarrassing 
0 1 2 3 4 5 6 7 
2. Felt guilty or 
ashamed 
0 1 2 3 4 5 6 7 
3. Performed 
poorly at school 
or work 
0 1 2 3 4 5 6 7 
4. Felt bad 
physically 
0 1 2 3 4 5 6 7 
5. Spent too 
much money or 
lost a lot of 
money 
0 1 2 3 4 5 6 7 
6. Missed school, 
work, or 
activities with 
friends 
0 1 2 3 4 5 6 7 
7. Done 
impulsive things 
you later 
regretted 
0 1 2 3 4 5 6 7 
8. Spent a 
significant 
amount of time 
thinking about, 
looking for, or 
using 
0 1 2 3 4 5 6 7 
9. Taken drugs 
in larger 
amounts or over 
longer period of 
time than you 
planned 
0 1 2 3 4 5 6 7 
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 Never Lifetime 
but not 
past 
year 
1-2 
occasions 
in past 
year 
3-5 
occasions 
in past 
year 
6-9 
occasions 
in past 
year 
10-19 
occasions 
in past 
year 
20-39 
occasions 
in past 
year 
40+ times 
in past year 
10. Failed to do 
what was 
expected of you 
0 1 2 3 4 5 6 7 
11. Need more 
drugs to get the 
same effect or 
don’t get the 
same effect with 
the usual amount 
0 1 2 3 4 5 6 7 
12. Lost interest 
in activities or 
hobbies 
0 1 2 3 4 5 6 7 
13. Been 
unhappy because 
of my stimulant 
use 
0 1 2 3 4 5 6 7 
14. Lost weight 
or not eaten 
properly because 
of my stimulant 
use 
0 1 2 3 4 5 6 7 
15. Gotten into a 
physical fight 
0 1 2 3 4 5 6 7 
16. Lost a close 
relationship 
0 1 2 3 4 5 6 7 
17. My 
personality has 
changed for the 
worse 
0 1 2 3 4 5 6 7 
18. Take more to 
avoid or reduce 
withdrawal 
0 1 2 3 4 5 6 7 
19. Gotten into 
legal trouble or 
arrested 
0 1 2 3 4 5 6 7 
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 Never Lifetime 
but not 
past 
year 
1-2 
occasions 
in past 
year 
3-5 
occasions 
in past 
year 
6-9 
occasions 
in past 
year 
10-19 
occasions 
in past 
year 
20-39 
occasions 
in past 
year 
40+ times 
in past year 
20. Been 
suspended,  
expelled from 
school, or fired 
from work 
0 1 2 3 4 5 6 7 
21. Enjoyed 
using drugs 
0 1 2 3 4 5 6 7 
22. While using 
stimulants I said 
harsh or cruel 
things to 
someone 
0 1 2 3 4 5 6 7 
23. Wanted or 
tried to limit, cut 
down, or stop 
0 1 2 3 4 5 6 7 
24. Continued to 
use despite 
psychological or 
physical 
consequence 
0 1 2 3 4 5 6 7 
25. Needed 
medical 
treatment 
0 1 2 3 4 5 6 7 
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Medication Knowledge 
 
1.   Please indicate the extent to which you agree/disagree with the following statement: I 
consider myself to be knowledgeable about the side effects associated with the use of 
stimulant medication normally used to treat ADHD (e.g., Adderall, Ritalin, Vyvanse).  
 
1. Strongly Disagree 
2. Disagree 
3. Neither 
4. Agree 
5. Strongly Agree 
 
2.   Have you ever been exposed to information about the side effects associated with the 
use of stimulant medication normally used to treat ADHD (e.g., Adderall, Ritalin, 
Vyvanse)? (Please indicate all sources that apply)  
 
No I have not 
Internet 
Magazine 
Healthcare facility pamphlet 
In class 
Information session 
Other students/friends 
Parents 
Television 
Books 
Other  
 
3.   Individuals taking stimulant medication may experience the following short term or 
long term side effects and/or adverse consequences (Please answer “Yes,” for those 
that are side effects, “No” for those that are not side effects, and “Don’t know” if you 
do not know the answer):   
 
 Yes No Don’t know 
Nighttime wakefulness (insomnia) Yes No Don’t know 
Increase in blood pressure Yes No Don’t know 
Sore throat Yes No Don’t know 
Increase in heart rate Yes No Don’t know 
Reductions in appetite Yes No Don’t know 
Adverse psychiatric problems Yes No Don’t know 
Sudden death Yes No Don’t know 
Nausea Yes No Don’t know 
Cardiovascular adverse reactions Yes No Don’t know 
Dry mouth Yes No Don’t know 
Headache Yes No Don’t know 
Abdominal pain Yes No Don’t know 
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Vomiting Yes No Don’t know 
Agitation Yes No Don’t know 
Anxiety Yes No Don’t know 
Dizziness Yes No Don’t know 
Tachycardia (excessively rapid heartbeat) Yes No Don’t know 
Diarrhea Yes No Don’t know 
 
4.   Below are contraindications (specific situations in which a drug should not be used 
because it may be harmful) listed for stimulant medications that may or may not be 
true (Please answer “True,” for those that are contraindications, “False” for those that 
are not contraindications, and “Don’t know” if you do not know the answer):   
 True False Don’t know 
History of drug abuse True False Don’t know 
Hyperthyroidism True False Don’t know 
Glaucoma True False Don’t know 
Serious cardiac (heart) problems True False Don’t know 
During or within 14 days following MAOI 
(antidepressant medication) use 
True False Don’t know 
Crohn’s disease True False Don’t know 
Migraines True False Don’t know 
Influenza True False Don’t know 
 
5.   What would you want your last meal to be?* ________________________ 
*(Quality assurance question #2) 
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Attitudes (TPB) 
 
Please rate the extent to which you agree or disagree with each of the following questions 
(Choose one):  strongly disagree, moderately disagree, somewhat disagree, no opinion, 
somewhat agree, moderately agree, strongly agree. 
 
1.   It is ethical for people without diagnosed ADHD to use stimulant medication for any 
reason. 
 
2.   It is ethical for people diagnosed with ADHD to use stimulant medication in excess or 
for purposes other than prescribed by a physician. 
 
3.   It is ethical for people with diagnosed ADHD to use stimulant medication to lose 
weight/control appetite. 
 
4.   It is ethical for people without diagnosed ADHD to use stimulant medication to lose 
weight/control appetite. 
 
5.   I believe it is safe for people to use stimulant medication in excess or for purposes 
other than prescribed by a physician. 
 
6.   I am concerned that taking stimulant medication in excess or for purposes other than 
prescribed by a physician will adversely affect a person’s health. 
 
7.   I am concerned that taking stimulant medication to lose weight/control appetite will 
adversely affect a person’s health. 
 
8.   I feel that the benefits of using a prescription stimulant medication without a doctor’s  
orders for any reason outweigh the potential risks. 
 
9.   I feel that the benefits of someone misusing their own prescription stimulant 
medication for any reason outweigh the potential risks. 
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Subjective Norms (TPB) 
 
Please rate the extent to which you agree or disagree with each of the following questions 
(Choose one):  strongly disagree, moderately disagree, somewhat disagree, no opinion, 
somewhat agree, moderately agree, strongly agree. 
 
1.   It is socially acceptable for people without diagnosed ADHD to use stimulant 
medication for any reason. 
 
2.   It is socially acceptable for people diagnosed with ADHD to use stimulant medication 
in excess or for purposes other than prescribed by a physician. 
 
3.   My friends/family/significant other believe that it is ok for people without diagnosed 
ADHD to use stimulant medication for any reason. 
 
4.   My friends/family/significant other believe that it is ok for people diagnosed with 
ADHD to use medication in excess or for purposes other than prescribed. 
 
5.   I know at least one person (e.g., family member/friend/significant other) who uses 
stimulant medications for the purpose of weight loss/appetite suppression without a 
doctor’s prescription. 
 
6.   I know at least one person (e.g., family member/friend/significant other) who misuses 
his/her own stimulant medication for the purpose of weight loss/appetite suppression. 
 
7.   I value my friends’/ family’s/significant other’s opinion on whether or not it is ok for 
people with a prescription to use the stimulant medication in excess or for purposes 
other than prescribed.  
 
8.   I value my friends’/ family’s/significant other’s opinion on whether or not it is ok for 
people without a prescription to use the stimulant medication for any reason.  
 
9.   I believe the use of stimulant medication by people without diagnosed ADHD, is 
common. 
 
10.  I believe the use of stimulant medication by people diagnosed with ADHD in excess 
or for purposes other than prescribed, is common.  
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Perceived Behavioral Control (TPB) 
 
Please rate the extent to which you agree or disagree with each of the following questions 
(Choose one):  strongly disagree, moderately disagree, somewhat disagree, no opinion, 
somewhat agree, moderately agree, strongly agree. 
 
1.   I feel I do not need stimulant medication to help me lose weight/control my appetite. 
 
2.   I am confident that I could get a stimulant medication from someone if I wanted to. 
 
3.   I feel I could lose weight successfully without the help of a stimulant medication. 
 
4.   I know people that would give/sell me a prescription stimulant medication if I wanted 
it.   
 
 
Please check the number four below:* 
 
1 2 3 4 5 6 
 
*(Quality assurance question #3) 	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Disordered Eating Attitudes/Behaviors (Past 28 Days; EDE-Q) 
 
Instructions: The following questions are concerned with the past four weeks (28 days) only. 
Please read each question carefully. Please answer all the questions.  
 
Questions 1 to 12: Please choose the appropriate response. Remember that questions 
only refer to the past four weeks (28 days) only. 
 
On how many of the past 28 days... 
 
1. Have you been deliberately trying to limit the amount of food you eat to influence your 
shape or weight (whether or not you have succeeded)? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
2. Have you gone for long periods of time (8 waking hours or more) without eating anything 
at all in order to influence your shape or weight? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
3. Have you tried to exclude from your diet any foods that you like in order to influence your 
shape or weight (whether or not you have succeeded)? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
4. Have you tried to follow definite rules regarding your eating (for example, a calorie limit) 
in order to influence your shape or weight (whether or not you have succeeded)? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
5. Have you had a definite desire to have an empty stomach with the aim of influencing your 
shape or weight? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
6. Have you had a definite desire to have a totally flat stomach? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
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7. Has thinking about food, eating, or calories made it very difficult to concentrate on things 
you are interested in (for example, working, following a conversation, or reading)? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
8. Has thinking about shape or weight made it very difficult to concentrate on things you are 
interested in (for example, working, following a conversation, or reading)? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
9. Have you had a definite fear of losing control over eating? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
10. Have you had a definite fear that you might gain weight? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
11. Have you felt fat? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
12. Have you had a strong desire to lose weight? 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
 
Questions 13-18: Please fill in the appropriate number on the line below. Remember 
that the questions only refer to the past four weeks (28 days). 
 
Over the past four weeks (28 days)... 
 
13. Over the past 28 days, how many times have you eaten what other people would regard 
as an unusually large amount of food (given the circumstances)? 
 
_____________ 
 
14. ... On how many of these times did you have a sense of having lost control over your 
eating (at the time that you were eating)? 
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_____________ 
 
15. Over the past 28 days, on how many DAYS have such episodes of overeating occurred 
(i.e., you have eaten an unusually large amount of food and have had a sense of loss of 
control at the time)? 
 
_____________ 
16. Over the past 28 days, how many times have you made yourself sick (vomit) as a means 
of controlling your shape or weight? 
 
_____________ 
 
17. Over the past 28 days, how many times have you taken laxatives as a means of 
controlling your shape or weight? 
 
_____________ 
 
18. Over the past 28 days, how many times have you exercised in a “driven” or “compulsive” 
way as a means of controlling your weight, shape or amount of fat, or to burn off calories? 
 
_____________ 
 
Questions 19 to 21: Please choose the appropriate response. Please note that for these 
questions the term “binge eating” means eating what others would regard as an 
unusually large amount of food for the circumstances, accompanied by a sense of 
having lost control over eating. 
 
19. Over the past 28 days, on how many days have you eaten in secret (i.e., furtively)? 
... Do not count episodes of binge eating 
 
0 1 2 3 4 5 6 
No days 1-5 days 6-12 days 13-15 days 16-22 days 23-27 days Every day 
 
20. On what proportion of the times that you have eaten have you felt guilty (felt that you’ve 
done wrong) because of its effect on your shape or weight? 
... Do not count episodes of binge eating 
 
0 1 2 3 4 5 6 
None of 
the times 
A few of 
the times 
Less than 
half 
Half of the 
times 
More than 
half 
Most of the 
time 
Every time 
 
21. Over the past 28 days, how concerned have you been about other people seeing you eat? 
... Do not count episodes of binge eating 
 
0 1 2 3 4 5 6 
Not at all  Slightly  Moderately  Markedly 
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Questions 22 to 28: Please choose the appropriate response. Remember that the 
questions only refer to the past four weeks (28 days). 
 
Over the past 28 days... 
 
22. Has your weight influenced how you think about (judge) yourself as a person? 
 
0 1 2 3 4 5 6 
Not at all  Slightly  Moderately  Markedly 
 
23. Has your shape influenced how you think about (judge) yourself as a person? 
 
0 1 2 3 4 5 6 
Not at all  Slightly  Moderately  Markedly 
 
24. How much would it have upset you if you had been asked to weigh yourself once a week 
(no more, or less, often) for the next four weeks? 
 
0 1 2 3 4 5 6 
Not at all  Slightly  Moderately  Markedly 
 
25. How dissatisfied have you been with your weight? 
 
0 1 2 3 4 5 6 
Not at all  Slightly  Moderately  Markedly 
 
26. How dissatisfied have you been with your shape? 
 
0 1 2 3 4 5 6 
Not at all  Slightly  Moderately  Markedly 
 
27. How uncomfortable have you felt seeing your body (for example, seeing your shape in 
the mirror, in a shop window reflection, while undressing or taking a bath or shower)? 
 
0 1 2 3 4 5 6 
Not at all  Slightly  Moderately  Markedly 
 
28. How uncomfortable have you felt about others seeing your shape or figure (for example, 
in communal changing rooms, when swimming, or wearing tight clothes)? 
 
0 1 2 3 4 5 6 
Not at all  Slightly  Moderately  Markedly 
 
 
 
	  123 
Healthy and Unhealthy Weight Loss Behaviors (Past 12 Months) 
 
1. How often have you done each of the following things in order to lose weight or keep from 
gaining weight during the past year? 
 
 Never Rarely Sometimes On a 
regular 
basis 
Fasted 1 2         3           4 
Ate very little food 1 2         3           4 
Exercise 1 2 3 4 
Took diet pills 1 2 3 4 
Ate more fruits and vegetables 1 2 3 4 
Ate less high-fat foods 1 2 3 4 
Used diuretics (water pills) 1 2 3 4 
Ate less sweets 1 2 3 4 
Used food substitute (powder/special 
drink) 
1 2 3 4 
Drank less soda pop (not including diet 
soda) 
1 2 3 4 
Skipped meals 1 2 3 4 
Smoked more cigarettes 1 2 3 4 
Watched my portion sizes (serving sizes) 1 2 3 4 
Followed a high protein/low 
carbohydrate diet (e.g., Atkins or other) 
1 2 3 4 
Drank energy drinks (e.g., Red Bull, 
Monster) 
1 2 3 4 
While watching the television, how often 
have you ever had a fatal heart attack?* 
*(Quality assurance question #4) 
1 2 3 4 
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Body Dissatisfaction (MBSRQ; Appearance Evaluation Subscale) 
 
 
Please read each of the 
following items carefully and 
indicate the number that best 
reflects your agreement with 
the statement. 
Definitely 
Disagree 
Mostly 
Disagree 
Neither 
Agree Nor 
Disagree 
Mostly 
Agree 
Definitely 
Agree 
1. My body is sexually 
appealing. 
1 2 3 4 5 
2. I like my looks just the way 
they are. 
1 2 3 4 5 
3. Most people would consider 
me good-looking. 
1 2 3 4 5 
4. I like the way I look without 
my clothes on.  
1 2 3 4 5 
5. I like the way my clothes fit 
me. 
1 2 3 4 5 
6. I dislike my physique. 1 2 3 4 5 
7. I am physically unattractive. 1 2 3 4 5 
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Media Influence on Body Image (SATAQ-3; Pressures Subscale) 
 
Please read each of the following 
items carefully and indicate the 
number that best reflects your 
agreement with the statement. 
 
Definitely 
Disagree  
Mostly 
Disagree  
Neither 
Agree 
Nor 
Disagree  
Mostly 
Agree  
Definitely 
Agree 
1. I've felt pressure from TV or 
magazines to lose weight. 
1 2 3 4 5 
2. I do not feel pressure from TV or 
magazines to look pretty (or 
muscular).     
1 2 3 4 5 
3. I've felt pressure from TV and 
magazines to be thin (or muscular). 
1 2 3 4 5 
4. I've felt pressure from TV or 
magazines to have a perfect body. 
1 2 3 4 5 
5. I've felt pressure from TV or 
magazines to diet.  
1 2 3 4 5 
6. I've felt pressure from TV or 
magazines to exercise.                                                                    
1 2 3 4 5 
7. I've felt pressure from TV or 
magazines to change my 
appearance.                                              
1 2 3 4 5 
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Depressive Symptomatology (CESD-R) 
 
Below is a list of the ways you might 
have felt or behaved. Please check the 
boxes to tell me how often you have 
felt this way in the past week or so. 
Not at all 
or less than 
1 day 
1 - 2 days 3 - 4 days 5 - 7 days Nearly every 
day for 2 
weeks 
1. My appetite was poor. 0 1 2 3 4 
2. I could not shake off the blues. 0 1 2 3 4 
3. I had trouble keeping my mind on 
what I was doing. 
0 1 2 3 4 
4. I felt depressed. 0 1 2 3 4 
5. My sleep was restless. 0 1 2 3 4 
6. I felt sad. 0 1 2 3 4 
7. I could not get going. 0 1 2 3 4 
8. Nothing made me happy. 0 1 2 3 4 
9. I felt like a bad person. 0 1 2 3 4 
10. I lost interest in my usual 
activities. 
0 1 2 3 4 
11. I slept much more than usual.  0 1 2 3 4 
12. I felt like I was moving too slowly. 0 1 2 3 4 
13. I felt fidgety. 0 1 2 3 4 
14. I wished I were dead. 0 1 2 3 4 
15. I wanted to hurt myself. 0 1 2 3 4 
16. I was tired all the time. 0 1 2 3 4 
17. I did not like myself. 0 1 2 3 4 
18. I lost a lot of weight without trying 
to. 
0 1 2 3 4 
19. I had a lot of trouble getting to 
sleep. 
0 1 2 3 4 
20. I could not focus on the important 
things. 
0 1 2 3 4 
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Other Substance Use 
Please indicate on 
how many occasions 
(if any) you have 
used the following in 
the past year: 
No 
occasions 
1-2 
occasions 
3-5 
occasions 
6-9 
occasions 
10-19 
occasions 
20-39 
occasions 
40 or more 
occasions 
Energy Drinks 1 2 3 4 5 6 7 
Tobacco products 
(Cigarettes, water 
pipe, cigars, 
smokeless 
tobacco)   
1 2 3 4 5 6 7 
Alcohol (beer, wine, 
liquor)   
1 2 3 4 5 6 7 
Marijuana (pot, 
weed, hashish, hash 
oil)  
1 2 3 4 5 6 7 
Cocaine (crack, 
rock, freebase, 
powder)  
1 2 3 4 5 6 7 
Methamphetamine 
(crystal meth, ice, 
crank)  
1 2 3 4 5 6 7 
Other 
amphetamines 
(bennies) 
1 2 3 4 5 6 7 
Anabolic steroids 
(Testosterone)   
1 2 3 4 5 6 7 
Opiates (heroin, 
smack) 
1 2 3 4 5 6 7 
MDMA (Ecstasy)   1 2 3 4 5 6 7 
 
If you have used any other recreational drugs in the past year please list them. 
_________________ 
1. What do you think the purpose of this study was? (Please make your best guess.)*  
_______________________ 
*(Quality assurance question #5) 
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